| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | TAP1 binding | 3.67e-10 | 10 | 223 | 6 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 3.67e-10 | 10 | 223 | 6 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 3.67e-10 | 10 | 223 | 6 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 1.58e-09 | 12 | 223 | 6 | GO:0030881 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.02e-08 | 9 | 223 | 5 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.02e-08 | 9 | 223 | 5 | GO:0062061 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 5.23e-08 | 32 | 223 | 7 | GO:0042288 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 6.17e-08 | 20 | 223 | 6 | GO:0042608 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 9.21e-07 | 17 | 223 | 5 | GO:0046703 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RALGAPA1 LRRK2 ARHGEF11 BCR NF1 RAB3GAP2 RGPD3 ARHGAP29 RGPD5 RANBP2 RGPD8 LARS1 TBC1D25 | 3.28e-06 | 279 | 223 | 14 | GO:0005096 |
| GeneOntologyMolecularFunction | MHC protein binding | 3.66e-06 | 58 | 223 | 7 | GO:0042287 | |
| GeneOntologyMolecularFunction | peptide binding | HLA-A HLA-B HLA-C HLA-G HLA-H KPNA7 TAP1 KPNA1 KPNA4 NUP98 LDLR LNPEP LRP1 ENPEP | 1.46e-05 | 318 | 223 | 14 | GO:0042277 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RALGAPA1 ITGB1BP1 LRRK2 ARHGEF11 BCR CHRM4 NF1 RAB3GAP2 RGPD3 ARHGAP29 BCAR3 RGPD5 RALGDS RANBP2 RGPD8 LARS1 TBC1D25 | 1.69e-05 | 507 | 223 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RALGAPA1 ITGB1BP1 LRRK2 ARHGEF11 BCR CHRM4 NF1 RAB3GAP2 RGPD3 ARHGAP29 BCAR3 RGPD5 RALGDS RANBP2 RGPD8 LARS1 TBC1D25 | 1.69e-05 | 507 | 223 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.70e-05 | 49 | 223 | 6 | GO:0042605 | |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 4.65e-05 | 7 | 223 | 3 | GO:0016907 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 6.37e-05 | 20 | 223 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.01e-04 | 42 | 223 | 5 | GO:0071889 | |
| GeneOntologyMolecularFunction | anaphase-promoting complex binding | 1.10e-04 | 9 | 223 | 3 | GO:0010997 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 1.87e-04 | 26 | 223 | 4 | GO:0070006 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.17e-04 | 27 | 223 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.34e-04 | 50 | 223 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 3.08e-04 | 53 | 223 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity | 3.62e-04 | 13 | 223 | 3 | GO:0099528 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor activity | 3.70e-04 | 3 | 223 | 2 | GO:0005010 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.76e-04 | 156 | 223 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | glucosidase activity | 5.66e-04 | 15 | 223 | 3 | GO:0015926 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 6.74e-04 | 36 | 223 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.49e-04 | 37 | 223 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.91e-04 | 18 | 223 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.05e-03 | 103 | 223 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.21e-03 | 5 | 223 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.21e-03 | 5 | 223 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 1.33e-03 | 43 | 223 | 4 | GO:0004177 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.33e-03 | 43 | 223 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.36e-03 | 20 | 223 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.46e-03 | 192 | 223 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 1.81e-03 | 22 | 223 | 3 | GO:0004993 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 2.06e-03 | 23 | 223 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | signal sequence binding | 2.51e-03 | 51 | 223 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 2.51e-03 | 7 | 223 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 2.51e-03 | 7 | 223 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.51e-03 | 7 | 223 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.64e-03 | 25 | 223 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RALGAPA1 LRRK2 ARHGEF11 BCR FZR1 NF1 RAB3GAP2 RGPD3 ARHGAP29 RGPD5 RANBP2 RGPD8 LARS1 TBC1D25 CDC20 | 2.96e-03 | 656 | 223 | 16 | GO:0008047 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 LRRK2 RAB3GAP2 RGPD3 RANBP2 DMXL2 RGPD8 ODF2 IPO13 XPOT | 3.38e-03 | 321 | 223 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.66e-03 | 28 | 223 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.73e-11 | 20 | 221 | 8 | GO:0006607 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.24e-10 | 18 | 221 | 7 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 7.36e-09 | 8 | 221 | 5 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 1.08e-08 | 41 | 221 | 8 | GO:0002474 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 3.95e-08 | 32 | 221 | 7 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.23e-07 | 23 | 221 | 6 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.85e-07 | 58 | 221 | 8 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.11e-07 | 25 | 221 | 6 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.11e-07 | 25 | 221 | 6 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 5.35e-07 | 16 | 221 | 5 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 7.47e-07 | 48 | 221 | 7 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 7.52e-07 | 17 | 221 | 5 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 7.52e-07 | 17 | 221 | 5 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.03e-06 | 18 | 221 | 5 | GO:0002428 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD4 LRRK2 KPNA7 NF1 RGPD3 KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 NUP98 IPO13 | 1.36e-06 | 195 | 221 | 12 | GO:0006606 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.54e-06 | 76 | 221 | 8 | GO:0048002 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 1.55e-06 | 9 | 221 | 4 | GO:0042270 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.55e-06 | 9 | 221 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD4 LRRK2 KPNA7 NF1 RGPD3 KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 NUP98 IPO13 | 1.87e-06 | 201 | 221 | 12 | GO:0051170 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 LRRK2 IRS1 KPNA7 NF1 RGPD3 DCLK2 KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 SYNE1 NUP98 IPO13 PYGO1 | 1.99e-06 | 362 | 221 | 16 | GO:0034504 |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.56e-06 | 10 | 221 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 2.60e-06 | 139 | 221 | 10 | GO:0019882 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 LRRK2 KPNA7 NF1 RGPD3 PKD1 NUP160 KPNA1 RGPD5 THOC1 KPNA4 RANBP2 RGPD8 NUP98 IPO13 XPOT | 3.46e-06 | 378 | 221 | 16 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 LRRK2 KPNA7 NF1 RGPD3 PKD1 NUP160 KPNA1 RGPD5 THOC1 KPNA4 RANBP2 RGPD8 NUP98 IPO13 XPOT | 3.46e-06 | 378 | 221 | 16 | GO:0006913 |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 5.37e-06 | 42 | 221 | 6 | GO:0001916 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 8.50e-06 | 13 | 221 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 LRRK2 BCR SORT1 SPTBN5 KPNA7 RINT1 NF1 RAB4B RAB3GAP2 SYNE2 RGPD3 VPS13A PKD1 MTMR2 CORO7 TAP1 NUP160 KPNA1 RGPD5 THOC1 KPNA4 RANBP2 RGPD8 SYNE1 NUP98 DYNC2I1 SYBU LDLR IGF2R LRP1 IPO13 SERAC1 REPS2 XPOT | 1.01e-05 | 1496 | 221 | 35 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.18e-05 | 14 | 221 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 2.13e-05 | 53 | 221 | 6 | GO:0001914 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | 6.53e-05 | 8 | 221 | 3 | GO:0007197 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 9.32e-05 | 43 | 221 | 5 | GO:0001953 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 1.05e-04 | 70 | 221 | 6 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 1.43e-04 | 74 | 221 | 6 | GO:0002711 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 LRRK2 SORT1 KPNA7 NF1 RAB3GAP2 RGPD3 VPS13A RAB4A KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 NUP98 IPO13 | 1.46e-04 | 515 | 221 | 16 | GO:0072594 |
| GeneOntologyBiologicalProcess | nuclear export | 1.78e-04 | 185 | 221 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.88e-04 | 11 | 221 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 2.05e-04 | 79 | 221 | 6 | GO:0001912 | |
| GeneOntologyBiologicalProcess | positive regulation of anaphase-promoting complex-dependent catabolic process | 3.40e-04 | 3 | 221 | 2 | GO:1905786 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 3.69e-04 | 88 | 221 | 6 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.84e-04 | 124 | 221 | 7 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of excitatory postsynaptic potential | 5.02e-04 | 15 | 221 | 3 | GO:0090394 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 5.77e-04 | 36 | 221 | 4 | GO:0007064 | |
| GeneOntologyBiologicalProcess | artery development | 5.86e-04 | 133 | 221 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | RNA transport | 6.15e-04 | 175 | 221 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 6.15e-04 | 175 | 221 | 8 | GO:0050657 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.79e-09 | 7 | 224 | 5 | GO:0032398 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 3.13e-09 | 23 | 224 | 7 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 3.96e-09 | 14 | 224 | 6 | GO:0042824 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.26e-08 | 10 | 224 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 3.26e-08 | 10 | 224 | 5 | GO:0042612 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.84e-08 | 20 | 224 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore | RGPD4 RGPD3 NUP160 KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 NUP98 XPOT | 1.34e-07 | 101 | 224 | 10 | GO:0005643 |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 7.53e-07 | 17 | 224 | 5 | GO:0033106 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 8.69e-07 | 8 | 224 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.03e-06 | 18 | 224 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.39e-06 | 21 | 224 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 3.99e-06 | 11 | 224 | 4 | GO:0032593 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 5.38e-06 | 42 | 224 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | MHC protein complex | 7.40e-06 | 26 | 224 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 CALR3 SORT1 WDR3 FZR1 SYNE2 RGPD3 NUP160 KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 SYNE1 NUP98 MAD2L1BP AKR7A2 IGF2R XPOT | 1.04e-05 | 560 | 224 | 19 | GO:0005635 |
| GeneOntologyCellularComponent | annulate lamellae | 1.18e-05 | 14 | 224 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 CYP4F8 CALR3 HLA-A HLA-B HLA-C PDGFRA LRRK2 HLA-G HLA-H NRROS CHRM3 TRIM59 SORT1 RINT1 FDFT1 RAB3GAP2 SYNE2 RGPD3 VPS13A TAP1 AMFR RANBP2 RGPD8 TAPT1 SYNE1 CD1D THADA ICMT CYP4F12 SEL1L2 CYB5R4 | 1.41e-05 | 1327 | 224 | 32 | GO:0042175 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.37e-05 | 35 | 224 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | inclusion body | 5.19e-05 | 90 | 224 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 6.16e-05 | 125 | 224 | 8 | GO:0140534 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 ORC3 ARID1A WDR3 FZR1 ARID1B SYNE2 RGPD3 INTS11 PRPF19 HCFC2 TAF5 NUP160 KPNA1 RGPD5 THOC1 KPNA4 RANBP2 THEMIS WDR5B RGPD8 ARID4A SYNE1 TAF1B NUP98 MAU2 SF3B3 PRPF3 CDC20 HCFC1 XPOT | 7.15e-05 | 1377 | 224 | 31 | GO:0140513 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.01e-04 | 212 | 224 | 10 | GO:0030666 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.06e-04 | 135 | 224 | 8 | GO:0031985 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 1.38e-04 | 10 | 224 | 3 | GO:0042564 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.59e-04 | 48 | 224 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.06e-04 | 112 | 224 | 7 | GO:0055038 | |
| GeneOntologyCellularComponent | early endosome | HLA-A HLA-B HLA-C HLA-G HLA-H SLC5A7 SORT1 RAB4B MTMR2 RAB4A LDLR CD1D IGF2R LNPEP LRP1 | 2.27e-04 | 481 | 224 | 15 | GO:0005769 |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 2.49e-04 | 12 | 224 | 3 | GO:0031074 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 2.69e-04 | 83 | 224 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | cis-Golgi network | 3.06e-04 | 85 | 224 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | transport vesicle membrane | HLA-A HLA-B HLA-C SLC6A17 LRRK2 HLA-G HLA-H SLC5A7 RAB4B RAB4A DMXL2 | 3.39e-04 | 293 | 224 | 11 | GO:0030658 |
| GeneOntologyCellularComponent | nuclear membrane | RGPD4 SORT1 WDR3 FZR1 SYNE2 RGPD3 KPNA4 RANBP2 RGPD8 SYNE1 NUP98 MAD2L1BP | 4.07e-04 | 349 | 224 | 12 | GO:0031965 |
| GeneOntologyCellularComponent | early endosome membrane | 4.87e-04 | 212 | 224 | 9 | GO:0031901 | |
| GeneOntologyCellularComponent | Golgi stack | 5.29e-04 | 171 | 224 | 8 | GO:0005795 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 6.13e-04 | 16 | 224 | 3 | GO:0048188 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 6.16e-04 | 64 | 224 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | insulin receptor complex | 6.76e-04 | 4 | 224 | 2 | GO:0005899 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYP4F8 CALR3 HLA-A HLA-B HLA-C PDGFRA LRRK2 HLA-G HLA-H NRROS CHRM3 TRIM59 SORT1 RINT1 FDFT1 RAB3GAP2 SYNE2 VPS13A TAP1 AMFR TAPT1 CD1D THADA ICMT CYP4F12 SEL1L2 CYB5R4 | 6.98e-04 | 1293 | 224 | 27 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYP4F8 CALR3 HLA-A HLA-B HLA-C PDGFRA LRRK2 HLA-G HLA-H NRROS CHRM3 TRIM59 SORT1 RINT1 FDFT1 RAB3GAP2 SYNE2 VPS13A TAP1 AMFR TAPT1 CD1D THADA ICMT CYP4F12 SEL1L2 CYB5R4 | 7.48e-04 | 1299 | 224 | 27 | GO:0098827 |
| GeneOntologyCellularComponent | secretory vesicle | ILF2 HLA-B HLA-C SLC6A17 SPATA31A7 LRRK2 HLA-H SLC5A7 ITGAL SPATA31A6 PCYOX1L RAB4B PTX3 AGL VPS13A MTMR2 RAB4A MGAM DMXL2 SPATA31A3 NHLRC3 SPATA31A5 IGF2R SPATA31A1 LNPEP LRP1 | 8.89e-04 | 1246 | 224 | 26 | GO:0099503 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 STK26 ITGB1BP1 SORT1 RAB4B RGPD3 SCN5A MTMR2 RAB4A HSP90AA2P AMFR RANBP2 RGPD8 SYNE1 CCNF IGF2R LNPEP LRP1 CDC20 CYB5R4 HERC5 | 1.14e-03 | 934 | 224 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | vacuolar membrane | HLA-A HLA-B HLA-C ACP2 HLA-G HLA-H SORT1 VPS13A MTMR2 LDLR CD1D LNPEP LRP1 ENPEP | 1.20e-03 | 507 | 224 | 14 | GO:0005774 |
| GeneOntologyCellularComponent | secretory granule | ILF2 HLA-B HLA-C SPATA31A7 HLA-H ITGAL SPATA31A6 PCYOX1L RAB4B PTX3 AGL VPS13A RAB4A MGAM DMXL2 SPATA31A3 NHLRC3 SPATA31A5 IGF2R SPATA31A1 LNPEP LRP1 | 1.37e-03 | 1014 | 224 | 22 | GO:0030141 |
| GeneOntologyCellularComponent | transport vesicle | HLA-A HLA-B HLA-C SLC6A17 LRRK2 HLA-G HLA-H SLC5A7 SORT1 RAB4B MTMR2 RAB4A DMXL2 IGF2R | 1.49e-03 | 519 | 224 | 14 | GO:0030133 |
| GeneOntologyCellularComponent | lysosomal membrane | HLA-A HLA-B HLA-C ACP2 HLA-G HLA-H SORT1 VPS13A LDLR CD1D LNPEP LRP1 ENPEP | 1.51e-03 | 462 | 224 | 13 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | HLA-A HLA-B HLA-C ACP2 HLA-G HLA-H SORT1 VPS13A LDLR CD1D LNPEP LRP1 ENPEP | 1.51e-03 | 462 | 224 | 13 | GO:0098852 |
| GeneOntologyCellularComponent | coated vesicle | HLA-A HLA-B HLA-C HLA-G HLA-H SLC5A7 CHRM2 SORT1 LDLR IGF2R LRP1 | 1.82e-03 | 360 | 224 | 11 | GO:0030135 |
| GeneOntologyCellularComponent | membrane raft | HLA-A HLA-B HLA-C LRRK2 HLA-G HLA-H SLC5A7 IRS1 SCN5A LDLR IGF1R | 1.90e-03 | 362 | 224 | 11 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | HLA-A HLA-B HLA-C LRRK2 HLA-G HLA-H SLC5A7 IRS1 SCN5A LDLR IGF1R | 1.98e-03 | 364 | 224 | 11 | GO:0098857 |
| GeneOntologyCellularComponent | vacuole | GALC HLA-A HLA-B HLA-C ACP2 LRRK2 HLA-G HLA-H SORT1 VPS13A MTMR2 LARS1 TBC1D25 NHLRC3 IDUA LDLR CD1D LNPEP LRP1 ENPEP | 2.02e-03 | 913 | 224 | 20 | GO:0005773 |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.29e-03 | 215 | 224 | 8 | GO:0030662 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.35e-03 | 25 | 224 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 2.67e-03 | 54 | 224 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | recycling endosome | 2.79e-03 | 222 | 224 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | lysosome | GALC HLA-A HLA-B HLA-C ACP2 LRRK2 HLA-G HLA-H SORT1 VPS13A LARS1 NHLRC3 IDUA LDLR CD1D LNPEP LRP1 ENPEP | 2.93e-03 | 811 | 224 | 18 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | GALC HLA-A HLA-B HLA-C ACP2 LRRK2 HLA-G HLA-H SORT1 VPS13A LARS1 NHLRC3 IDUA LDLR CD1D LNPEP LRP1 ENPEP | 2.93e-03 | 811 | 224 | 18 | GO:0000323 |
| GeneOntologyCellularComponent | endocytic vesicle | HLA-A HLA-B HLA-C HLA-G HLA-H SLC5A7 CHRM2 TAP1 LDLR IGF2R LRP1 | 2.99e-03 | 384 | 224 | 11 | GO:0030139 |
| GeneOntologyCellularComponent | axon | PDGFRA MYOC LRRK2 SLC5A7 PLXND1 BCR CHRM2 CHRM3 CHRM4 NF1 SSH1 SCN5A MTMR2 AMFR SYBU IGF1R LRP1 HTR3B HCFC1 | 3.49e-03 | 891 | 224 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | transferase complex | RGPD4 IRS1 DCUN1D4 FZR1 RGPD3 HCFC2 TAF5 AMFR RANBP2 WDR5B SLF1 RGPD8 WWP1 CCNF IGF1R SF3B3 FBH1 CDC20 PIK3R5 HCFC1 | 3.70e-03 | 963 | 224 | 20 | GO:1990234 |
| GeneOntologyCellularComponent | cell surface | HLA-A HLA-B HLA-C PDGFRA HLA-G HLA-H NRROS ITGAL SORT1 DUOX1 SCN5A PKD1 C1QBP NID2 LDLR CD1D IGF2R LNPEP LRP1 HTR3B ENPEP IL4R | 4.17e-03 | 1111 | 224 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | vesicle membrane | HLA-A HLA-B HLA-C SLC6A17 STK26 LRRK2 HLA-G HLA-H SLC5A7 ITGAL CHRM2 SORT1 RAB4B VPS13A PKD1 MTMR2 TAP1 RAB4A MGAM DMXL2 LDLR CD1D IGF2R LNPEP LRP1 | 4.28e-03 | 1325 | 224 | 25 | GO:0012506 |
| GeneOntologyCellularComponent | inner dynein arm | 4.86e-03 | 10 | 224 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | bBAF complex | 4.86e-03 | 10 | 224 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 4.86e-03 | 10 | 224 | 2 | GO:0031080 | |
| GeneOntologyCellularComponent | plasma membrane raft | 5.12e-03 | 147 | 224 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | endosome membrane | HLA-A HLA-B HLA-C HLA-G HLA-H SLC5A7 SORT1 RAB4B VPS13A MTMR2 RAB4A LDLR CD1D IGF2R | 5.62e-03 | 602 | 224 | 14 | GO:0010008 |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 5.90e-03 | 11 | 224 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 5.90e-03 | 11 | 224 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 5.90e-03 | 11 | 224 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | hemidesmosome | 5.90e-03 | 11 | 224 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 5.90e-03 | 11 | 224 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.66e-03 | 110 | 224 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | caveola | 6.91e-03 | 111 | 224 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 7.01e-03 | 157 | 224 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-A HLA-B HLA-C SLC6A17 LRRK2 HLA-G HLA-H SLC5A7 ITGAL CHRM2 SORT1 RAB4B VPS13A PKD1 MTMR2 TAP1 RAB4A MGAM DMXL2 LDLR CD1D IGF2R LNPEP LRP1 | 7.07e-03 | 1307 | 224 | 24 | GO:0030659 |
| MousePheno | spinal cord inflammation | 1.53e-08 | 8 | 174 | 5 | MP:0030987 | |
| MousePheno | increased liver tumor incidence | RGPD4 STAG1 FZR1 RINT1 NF1 RGPD3 AMFR RANBP2 RGPD8 CCDC80 CDC20 | 1.31e-07 | 111 | 174 | 11 | MP:0008019 |
| MousePheno | increased hepatobiliary system tumor incidence | RGPD4 STAG1 FZR1 RINT1 NF1 RGPD3 AMFR RANBP2 RGPD8 CCDC80 CDC20 | 1.31e-07 | 111 | 174 | 11 | MP:0010297 |
| MousePheno | aneuploidy | 1.02e-05 | 61 | 174 | 7 | MP:0004024 | |
| MousePheno | decreased immature NK cell number | 2.11e-05 | 14 | 174 | 4 | MP:0013666 | |
| MousePheno | increased hepatocellular carcinoma incidence | 2.54e-05 | 70 | 174 | 7 | MP:0003331 | |
| MousePheno | abnormal liver morphology | RGPD4 RALGAPA1 STAG1 SLC5A7 METTL23 BCR FZR1 RINT1 KL NF1 AGL JAG1 RGPD3 SCN5A PKD1 IL17RA DNAH5 AMFR RANBP2 RGPD8 ARID4A CCDC80 PSTPIP2 IDUA CLDN12 LDLR MAD2L1BP CD1D CMIP IGF1R IGF2R ICMT LRP1 SERAC1 MAPK6 CDC20 | 3.03e-05 | 1433 | 174 | 36 | MP:0000598 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 3.75e-05 | 16 | 174 | 4 | MP:0003701 | |
| MousePheno | CNS inflammation | 5.37e-05 | 54 | 174 | 6 | MP:0006082 | |
| MousePheno | abnormal hepatobiliary system morphology | RGPD4 RALGAPA1 STAG1 SLC5A7 METTL23 BCR FZR1 RINT1 KL NF1 AGL JAG1 RGPD3 SCN5A PKD1 IL17RA DNAH5 AMFR RANBP2 RGPD8 ARID4A CCDC80 PSTPIP2 IDUA CLDN12 LDLR MAD2L1BP CD1D CMIP IGF1R IGF2R ICMT LRP1 SERAC1 MAPK6 CDC20 | 5.65e-05 | 1476 | 174 | 36 | MP:0002138 |
| MousePheno | decreased mature NK cell number | 6.19e-05 | 18 | 174 | 4 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 7.77e-05 | 19 | 174 | 4 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 7.77e-05 | 19 | 174 | 4 | MP:0013699 | |
| MousePheno | abnormal chromosome number | 9.64e-05 | 86 | 174 | 7 | MP:0004023 | |
| MousePheno | abnormal microglial cell morphology | 1.04e-04 | 87 | 174 | 7 | MP:0000136 | |
| MousePheno | abnormal pelvic girdle bone morphology | 1.04e-04 | 87 | 174 | 7 | MP:0004509 | |
| MousePheno | cystolithiasis | 1.42e-04 | 22 | 174 | 4 | MP:0011625 | |
| MousePheno | abnormal mitosis | 1.97e-04 | 128 | 174 | 8 | MP:0004046 | |
| MousePheno | abnormal mature NK cell number | 2.03e-04 | 24 | 174 | 4 | MP:0013671 | |
| MousePheno | abnormal oligodendrocyte progenitor morphology | 2.13e-04 | 10 | 174 | 3 | MP:0014325 | |
| MousePheno | abnormal atrioventricular valve morphology | 2.14e-04 | 69 | 174 | 6 | MP:0002745 | |
| MousePheno | abnormal lung morphology | RGPD4 PDGFRA PKD1L1 LRRK2 PLXND1 FZR1 RINT1 KL NF1 RGPD3 SCN5A PKD1 IL17RA DNAH5 RANBP2 RGPD8 SYNE1 TBC1D25 IGF1R IGF2R MAPK6 IL4R | 2.17e-04 | 767 | 174 | 22 | MP:0001175 |
| MousePheno | decreased susceptibility to autoimmune diabetes | 2.30e-04 | 45 | 174 | 5 | MP:0004804 | |
| MousePheno | abnormal mature NK cell morphology | 2.39e-04 | 25 | 174 | 4 | MP:0013700 | |
| MousePheno | abnormal morula morphology | 2.80e-04 | 26 | 174 | 4 | MP:0012058 | |
| MousePheno | increased sarcoma incidence | 2.81e-04 | 102 | 174 | 7 | MP:0002032 | |
| MousePheno | abnormal heart atrium and ventricle connection | 3.38e-04 | 75 | 174 | 6 | MP:0010435 | |
| MousePheno | abnormal interventricular septum morphology | EPHB4 PDGFRA SLC5A7 PLXND1 ARID1A NF1 JAG1 PKD1 DNAH5 HECTD1 IDUA CMIP IGF2R | 3.54e-04 | 342 | 174 | 13 | MP:0000281 |
| MousePheno | abnormal heart septum morphology | EPHB4 PDGFRA SLC5A7 PLXND1 ARID1A NF1 JAG1 PKD1 DNAH5 HECTD1 IDUA CMIP IGF2R LRP1 | 3.56e-04 | 388 | 174 | 14 | MP:0006113 |
| MousePheno | increased lung tumor incidence | 3.76e-04 | 107 | 174 | 7 | MP:0008014 | |
| MousePheno | increased respiratory system tumor incidence | 3.76e-04 | 107 | 174 | 7 | MP:0010298 | |
| MousePheno | increased lung carcinoma incidence | 4.18e-04 | 78 | 174 | 6 | MP:0008714 | |
| MousePheno | ventricular septal defect | EPHB4 PDGFRA SLC5A7 PLXND1 ARID1A NF1 JAG1 PKD1 DNAH5 HECTD1 CMIP | 4.29e-04 | 261 | 174 | 11 | MP:0010402 |
| MousePheno | hip dislocation | 4.58e-04 | 3 | 174 | 2 | MP:0030796 | |
| MousePheno | increased autopod size | 4.58e-04 | 3 | 174 | 2 | MP:0020242 | |
| MousePheno | decreased tumor latency | 4.94e-04 | 30 | 174 | 4 | MP:0010308 | |
| MousePheno | abnormal coronary sinus connection | 4.95e-04 | 13 | 174 | 3 | MP:0013975 | |
| MousePheno | abnormal cell nucleus morphology | 4.95e-04 | 184 | 174 | 9 | MP:0003111 | |
| MousePheno | abnormal kidney collecting duct morphology | 4.99e-04 | 53 | 174 | 5 | MP:0004754 | |
| MousePheno | failure of blastocyst formation | 5.61e-04 | 31 | 174 | 4 | MP:0012129 | |
| MousePheno | urolithiasis | 5.61e-04 | 31 | 174 | 4 | MP:0005360 | |
| MousePheno | increased cell migration | 6.24e-04 | 14 | 174 | 3 | MP:0011804 | |
| MousePheno | demyelination | 6.62e-04 | 85 | 174 | 6 | MP:0000921 | |
| Domain | - | LRRK2 ARID1A KPNA7 ARID1B NF1 UTP20 HECTD1 KPNA1 KPNA4 HEATR4 FRYL MROH6 IPO13 SERAC1 XPOT | 6.62e-08 | 222 | 221 | 15 | 1.25.10.10 |
| Domain | ARM-type_fold | RALGAPA1 STAG1 LRRK2 ARID1A KPNA7 NF1 UTP20 HECTD1 KPNA1 KPNA4 HEATR4 FRYL THADA MROH6 AOPEP IPO13 SERAC1 XPOT | 1.26e-07 | 339 | 221 | 18 | IPR016024 |
| Domain | ARM-like | STAG1 LRRK2 ARID1A KPNA7 ARID1B NF1 UTP20 HECTD1 KPNA1 KPNA4 HEATR4 FRYL MROH6 IPO13 SERAC1 XPOT | 1.47e-07 | 270 | 221 | 16 | IPR011989 |
| Domain | Ran_BP1 | 1.64e-07 | 12 | 221 | 5 | PF00638 | |
| Domain | RANBD1 | 1.64e-07 | 12 | 221 | 5 | PS50196 | |
| Domain | RanBD | 2.64e-07 | 13 | 221 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 2.64e-07 | 13 | 221 | 5 | IPR000156 | |
| Domain | MHC_I_a_C | 2.81e-07 | 6 | 221 | 4 | IPR010579 | |
| Domain | MHC_I_C | 2.81e-07 | 6 | 221 | 4 | PF06623 | |
| Domain | WD40/YVTN_repeat-like_dom | LRRK2 PLXND1 SORT1 WDR3 FZR1 PRPF19 WDR90 SEMA4A TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 SF3B3 CDC20 | 5.37e-07 | 335 | 221 | 17 | IPR015943 |
| Domain | - | LRRK2 PLXND1 SORT1 WDR3 FZR1 PRPF19 WDR90 SEMA4A TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 2.38e-06 | 333 | 221 | 16 | 2.130.10.10 |
| Domain | MHC_I | 3.87e-06 | 21 | 221 | 5 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 3.87e-06 | 21 | 221 | 5 | IPR001039 | |
| Domain | Grip | 5.90e-06 | 11 | 221 | 4 | SM00755 | |
| Domain | GRIP | 5.90e-06 | 11 | 221 | 4 | PF01465 | |
| Domain | REJ | 6.48e-06 | 4 | 221 | 3 | PS51111 | |
| Domain | REJ_dom | 6.48e-06 | 4 | 221 | 3 | IPR014010 | |
| Domain | - | 7.84e-06 | 24 | 221 | 5 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 7.84e-06 | 24 | 221 | 5 | IPR011161 | |
| Domain | GRIP_dom | 8.77e-06 | 12 | 221 | 4 | IPR000237 | |
| Domain | GRIP | 8.77e-06 | 12 | 221 | 4 | PS50913 | |
| Domain | DUF4599 | 8.77e-06 | 12 | 221 | 4 | PF15371 | |
| Domain | DUF4599 | 8.77e-06 | 12 | 221 | 4 | IPR027970 | |
| Domain | WD40_repeat_dom | LRRK2 WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 SF3B3 CDC20 | 1.28e-05 | 297 | 221 | 14 | IPR017986 |
| Domain | Musac_Ach_rcpt | 1.61e-05 | 5 | 221 | 3 | IPR000995 | |
| Domain | WD40 | LRRK2 WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 1.94e-05 | 268 | 221 | 13 | SM00320 |
| Domain | WD40_repeat | LRRK2 WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 2.27e-05 | 272 | 221 | 13 | IPR001680 |
| Domain | TPR_REGION | RGPD4 RGPD3 VPS13A RGPD5 RANBP2 RGPD8 DNAH2 MAU2 TTC29 CFAP46 | 2.78e-05 | 165 | 221 | 10 | PS50293 |
| Domain | TPR | RGPD4 RGPD3 VPS13A RGPD5 RANBP2 RGPD8 DNAH2 MAU2 TTC29 CFAP46 | 2.78e-05 | 165 | 221 | 10 | PS50005 |
| Domain | PKD/REJ-like | 3.18e-05 | 6 | 221 | 3 | IPR002859 | |
| Domain | REJ | 3.18e-05 | 6 | 221 | 3 | PF02010 | |
| Domain | C1-set | 4.12e-05 | 54 | 221 | 6 | PF07654 | |
| Domain | IGc1 | 5.08e-05 | 56 | 221 | 6 | SM00407 | |
| Domain | Arm_3 | 5.52e-05 | 7 | 221 | 3 | PF16186 | |
| Domain | PKD | 5.52e-05 | 7 | 221 | 3 | PF00801 | |
| Domain | Importing_su_alpha | 5.52e-05 | 7 | 221 | 3 | IPR024931 | |
| Domain | IBB | 5.52e-05 | 7 | 221 | 3 | PF01749 | |
| Domain | Rab_bind | 5.52e-05 | 7 | 221 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 5.52e-05 | 7 | 221 | 3 | IPR032023 | |
| Domain | Arm_3 | 5.52e-05 | 7 | 221 | 3 | IPR032413 | |
| Domain | Ig_C1-set | 6.21e-05 | 58 | 221 | 6 | IPR003597 | |
| Domain | WD40 | WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 6.34e-05 | 259 | 221 | 12 | PF00400 |
| Domain | MHC_I/II-like_Ag-recog | 8.10e-05 | 38 | 221 | 5 | IPR011162 | |
| Domain | IBB | 8.76e-05 | 8 | 221 | 3 | PS51214 | |
| Domain | WD_REPEATS_1 | WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 1.24e-04 | 278 | 221 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 1.28e-04 | 279 | 221 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 1.28e-04 | 279 | 221 | 12 | PS50294 |
| Domain | Importin-a_IBB | 1.30e-04 | 9 | 221 | 3 | IPR002652 | |
| Domain | PKD/Chitinase_dom | 1.30e-04 | 9 | 221 | 3 | IPR022409 | |
| Domain | PKD | 1.30e-04 | 9 | 221 | 3 | SM00089 | |
| Domain | BAF250/Osa | 1.39e-04 | 2 | 221 | 2 | IPR021906 | |
| Domain | BAF250_C | 1.39e-04 | 2 | 221 | 2 | IPR033388 | |
| Domain | BAF250_C | 1.39e-04 | 2 | 221 | 2 | PF12031 | |
| Domain | WD40_repeat_CS | 1.50e-04 | 164 | 221 | 9 | IPR019775 | |
| Domain | - | 1.84e-04 | 10 | 221 | 3 | 1.10.220.60 | |
| Domain | PKD | 2.51e-04 | 11 | 221 | 3 | PS50093 | |
| Domain | PKD_dom | 2.51e-04 | 11 | 221 | 3 | IPR000601 | |
| Domain | PKD_channel | 2.51e-04 | 11 | 221 | 3 | PF08016 | |
| Domain | PKD1_2_channel | 2.51e-04 | 11 | 221 | 3 | IPR013122 | |
| Domain | - | 2.51e-04 | 11 | 221 | 3 | 2.60.40.670 | |
| Domain | Peptidase_M1 | 3.32e-04 | 12 | 221 | 3 | IPR001930 | |
| Domain | Glycoside_hydrolase_SF | 4.01e-04 | 53 | 221 | 5 | IPR017853 | |
| Domain | Cdc20/Fizzy | 4.15e-04 | 3 | 221 | 2 | IPR033010 | |
| Domain | Peptidase_M1_N | 4.28e-04 | 13 | 221 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 4.28e-04 | 13 | 221 | 3 | PF01433 | |
| Domain | TPR-like_helical_dom | RGPD4 RGPD3 RGPD5 RANBP2 RGPD8 MAU2 CCNF TTC29 SEL1L2 CFAP46 | 4.74e-04 | 233 | 221 | 10 | IPR011990 |
| Domain | G-protein_beta_WD-40_rep | 5.15e-04 | 85 | 221 | 6 | IPR020472 | |
| Domain | Dynein_HC_stalk | 5.40e-04 | 14 | 221 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.40e-04 | 14 | 221 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.40e-04 | 14 | 221 | 3 | PF08393 | |
| Domain | MT | 5.40e-04 | 14 | 221 | 3 | PF12777 | |
| Domain | Ldl_recept_b | 5.40e-04 | 14 | 221 | 3 | PF00058 | |
| Domain | LDLRB | 5.40e-04 | 14 | 221 | 3 | PS51120 | |
| Domain | Ig/MHC_CS | 6.10e-04 | 58 | 221 | 5 | IPR003006 | |
| Domain | DHC_fam | 6.69e-04 | 15 | 221 | 3 | IPR026983 | |
| Domain | - | 6.69e-04 | 15 | 221 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 6.69e-04 | 15 | 221 | 3 | SM00501 | |
| Domain | ARID_dom | 6.69e-04 | 15 | 221 | 3 | IPR001606 | |
| Domain | ARID | 6.69e-04 | 15 | 221 | 3 | PS51011 | |
| Domain | Dynein_heavy | 6.69e-04 | 15 | 221 | 3 | PF03028 | |
| Domain | LY | 6.69e-04 | 15 | 221 | 3 | SM00135 | |
| Domain | ARID | 6.69e-04 | 15 | 221 | 3 | PF01388 | |
| Domain | Dynein_heavy_dom | 6.69e-04 | 15 | 221 | 3 | IPR004273 | |
| Domain | LDLR_classB_rpt | 6.69e-04 | 15 | 221 | 3 | IPR000033 | |
| Domain | IG_MHC | 7.13e-04 | 60 | 221 | 5 | PS00290 | |
| Domain | - | 7.49e-04 | 35 | 221 | 4 | 3.20.20.80 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | IPR012315 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | PS51049 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | SM01249 | |
| Domain | KASH | 8.23e-04 | 4 | 221 | 2 | PF10541 | |
| Domain | - | 8.26e-04 | 207 | 221 | 9 | 1.25.40.10 | |
| Domain | GPS | 8.35e-04 | 36 | 221 | 4 | PS50221 | |
| Domain | GPS | 9.28e-04 | 37 | 221 | 4 | IPR000203 | |
| Domain | Glyco_hydro_catalytic_dom | 1.03e-03 | 38 | 221 | 4 | IPR013781 | |
| Domain | - | 1.13e-03 | 39 | 221 | 4 | 2.120.10.30 | |
| Domain | LH2 | 1.17e-03 | 18 | 221 | 3 | SM00308 | |
| Domain | Sortilin_C | 1.36e-03 | 5 | 221 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.36e-03 | 5 | 221 | 2 | PF15902 | |
| Domain | VPS10 | 1.36e-03 | 5 | 221 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.36e-03 | 5 | 221 | 2 | IPR031778 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.92e-10 | 9 | 165 | 6 | MM14527 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 3.88e-08 | 18 | 165 | 6 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 7.94e-08 | 20 | 165 | 6 | MM1374 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 9.02e-08 | 11 | 165 | 5 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.53e-07 | 12 | 165 | 5 | M47529 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.67e-07 | 6 | 165 | 4 | M47468 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.46e-07 | 25 | 165 | 6 | MM15713 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 6.16e-07 | 7 | 165 | 4 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 6.16e-07 | 7 | 165 | 4 | M47530 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.48e-06 | 40 | 165 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 7.52e-06 | 41 | 165 | 6 | MM15200 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 7.52e-06 | 41 | 165 | 6 | M29574 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 8.69e-06 | 42 | 165 | 6 | MM15039 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 9.09e-06 | 25 | 165 | 5 | MM1465 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.00e-05 | 43 | 165 | 6 | MM14609 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 1.55e-05 | 5 | 165 | 3 | M27300 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 1.55e-05 | 5 | 165 | 3 | MM15006 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.69e-05 | 126 | 165 | 9 | M45009 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.69e-05 | 47 | 165 | 6 | MM14939 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.96e-05 | 29 | 165 | 5 | M1062 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | ILF2 HLA-A HLA-B HLA-C HLA-G HLA-H KPNA7 NUP160 KPNA1 KPNA4 RANBP2 NUP98 HERC5 | 1.96e-05 | 273 | 165 | 13 | M983 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.16e-05 | 49 | 165 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.44e-05 | 50 | 165 | 6 | MM14610 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 2.47e-05 | 74 | 165 | 7 | M48006 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.73e-05 | 51 | 165 | 6 | MM15151 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 2.94e-05 | 76 | 165 | 7 | MM14526 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.23e-05 | 55 | 165 | 6 | MM14917 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 4.87e-05 | 18 | 165 | 4 | MM1549 | |
| Pathway | KEGG_ENDOCYTOSIS | HLA-A HLA-B HLA-C PDGFRA HLA-G SH3GLB2 RAB4A WWP1 LDLR IGF1R | 5.33e-05 | 181 | 165 | 10 | M1519 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.63e-05 | 84 | 165 | 7 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.74e-05 | 58 | 165 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.74e-05 | 58 | 165 | 6 | MM14736 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.55e-05 | 86 | 165 | 7 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.10e-04 | 65 | 165 | 6 | MM15147 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.36e-04 | 129 | 165 | 8 | MM14894 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.70e-04 | 100 | 165 | 7 | MM14561 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.87e-04 | 135 | 165 | 8 | MM14781 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | HLA-A HLA-B HLA-C HLA-G HLA-H UBE2R2 FZR1 HECTD1 TAP1 WWP1 CCNF LNPEP CDC20 | 2.00e-04 | 343 | 165 | 13 | MM15712 |
| Pathway | REACTOME_SARS_COV_2_INFECTION | MAN2A1 HLA-A HLA-B HLA-C HLA-G IL17RA NUP160 RANBP2 NUP98 ST3GAL1 ANO10 MASP2 | 2.09e-04 | 299 | 165 | 12 | M41727 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.09e-04 | 73 | 165 | 6 | MM14948 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 3.01e-04 | 78 | 165 | 6 | M973 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.94e-04 | 82 | 165 | 6 | MM15394 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.00e-04 | 151 | 165 | 8 | M550 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 4.11e-04 | 54 | 165 | 5 | MM14871 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.47e-04 | 117 | 165 | 7 | MM15387 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | HLA-A HLA-B HLA-C HLA-G UBE2R2 FZR1 HECTD1 TAP1 WWP1 CCNF LNPEP CDC20 HERC5 | 5.46e-04 | 381 | 165 | 13 | M1066 |
| Pathway | WP_ALLOGRAFT_REJECTION | 6.12e-04 | 89 | 165 | 6 | M39398 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.23e-04 | 202 | 165 | 9 | MM15362 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 6.68e-04 | 204 | 165 | 9 | M45011 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 7.30e-04 | 92 | 165 | 6 | MM14951 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 8.01e-04 | 129 | 165 | 7 | M39693 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 8.84e-04 | 37 | 165 | 4 | M18615 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 8.84e-04 | 37 | 165 | 4 | M1029 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.31e-03 | 41 | 165 | 4 | M13519 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.35e-03 | 141 | 165 | 7 | MM15266 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.36e-03 | 70 | 165 | 5 | M12294 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.53e-03 | 106 | 165 | 6 | M518 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.57e-03 | 43 | 165 | 4 | M12617 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | RGPD4 RGPD3 PRPF19 NUP160 THOC1 RANBP2 RGPD8 NUP98 SF3B3 PRPF3 | 1.58e-03 | 277 | 165 | 10 | MM15414 |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.92e-03 | 150 | 165 | 7 | M39520 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.97e-03 | 193 | 165 | 8 | MM14890 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_EMI1 | 1.98e-03 | 6 | 165 | 2 | M27035 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_EMI1 | 1.98e-03 | 6 | 165 | 2 | MM14691 | |
| Pubmed | The source of early IFN-gamma that plays a role in Th1 priming. | 1.44e-13 | 11 | 226 | 7 | 11489982 | |
| Pubmed | 3.43e-13 | 12 | 226 | 7 | 15699104 | ||
| Pubmed | 1.95e-12 | 8 | 226 | 6 | 15944272 | ||
| Pubmed | 1.95e-12 | 8 | 226 | 6 | 14530332 | ||
| Pubmed | 1.95e-12 | 8 | 226 | 6 | 17010536 | ||
| Pubmed | The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. | 1.95e-12 | 8 | 226 | 6 | 20038604 | |
| Pubmed | 2.74e-12 | 15 | 226 | 7 | 21964024 | ||
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 17128277 | ||
| Pubmed | Functional roles of TAP and tapasin in the assembly of M3-N-formylated peptide complexes. | 5.82e-12 | 9 | 226 | 6 | 11466371 | |
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 35617964 | ||
| Pubmed | Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. | 5.82e-12 | 9 | 226 | 6 | 19945389 | |
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 31757993 | ||
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 11754812 | ||
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 10510343 | ||
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 19864563 | ||
| Pubmed | An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. | 5.82e-12 | 9 | 226 | 6 | 18541714 | |
| Pubmed | Response to Listeria monocytogenes in mice lacking MHC class Ia molecules. | 5.82e-12 | 9 | 226 | 6 | 10228021 | |
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 11602646 | ||
| Pubmed | 5.82e-12 | 9 | 226 | 6 | 11046052 | ||
| Pubmed | 1.45e-11 | 10 | 226 | 6 | 9764360 | ||
| Pubmed | MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling. | 1.45e-11 | 10 | 226 | 6 | 25164678 | |
| Pubmed | Association of beta2-microglobulin with the alpha3 domain of H-2Db heavy chain. | 1.45e-11 | 10 | 226 | 6 | 14735325 | |
| Pubmed | 1.45e-11 | 10 | 226 | 6 | 12574368 | ||
| Pubmed | 1.45e-11 | 10 | 226 | 6 | 16002705 | ||
| Pubmed | ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. | 1.45e-11 | 10 | 226 | 6 | 23863903 | |
| Pubmed | 3.17e-11 | 11 | 226 | 6 | 38048225 | ||
| Pubmed | Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. | 3.17e-11 | 11 | 226 | 6 | 29358051 | |
| Pubmed | 3.17e-11 | 11 | 226 | 6 | 22522492 | ||
| Pubmed | 3.17e-11 | 11 | 226 | 6 | 10377186 | ||
| Pubmed | Ham-2 corrects the class I antigen-processing defect in RMA-S cells. | 6.30e-11 | 12 | 226 | 6 | 1538753 | |
| Pubmed | CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. | 6.30e-11 | 12 | 226 | 6 | 9133426 | |
| Pubmed | 6.62e-11 | 6 | 226 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.62e-11 | 6 | 226 | 5 | 25930072 | |
| Pubmed | 1.16e-10 | 13 | 226 | 6 | 9973410 | ||
| Pubmed | 2.03e-10 | 14 | 226 | 6 | 9021146 | ||
| Pubmed | Vitamin A-enhanced cleft palate susceptibility gene maps between C4 and B144 within the H-2 complex. | 2.03e-10 | 14 | 226 | 6 | 8456115 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 EPPK1 IRS1 PLXND1 ARID1A ARHGEF11 BCR CHRM4 FZR1 SSH1 SCN5A INTS11 PKD1 WDR90 HECTD1 ZNF426 HOXB13 WWP1 TBC1D25 ST3GAL1 FRYL IDUA LDLR THADA IGF1R IGF2R MROH6 IL4R HCFC1 | 2.06e-10 | 1105 | 226 | 29 | 35748872 |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 2.30e-10 | 7 | 226 | 5 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 2.30e-10 | 7 | 226 | 5 | 28234229 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 2642506 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 9037062 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 20957233 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 2.30e-10 | 7 | 226 | 5 | 20974936 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 2.30e-10 | 7 | 226 | 5 | 2908875 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 3458188 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 19462379 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 2.30e-10 | 7 | 226 | 5 | 6300850 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 2.30e-10 | 7 | 226 | 5 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 2.30e-10 | 7 | 226 | 5 | 2906539 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 3013627 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 3894562 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 2.30e-10 | 7 | 226 | 5 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 2.30e-10 | 7 | 226 | 5 | 18383043 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 8833240 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 2.30e-10 | 7 | 226 | 5 | 3025084 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 2.30e-10 | 7 | 226 | 5 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 2.30e-10 | 7 | 226 | 5 | 6786753 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 6583704 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 6571712 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 12006653 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 7520098 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 10452993 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 26714929 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 6280871 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 10799615 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 2.30e-10 | 7 | 226 | 5 | 19454713 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 10229092 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 2879284 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 7306483 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 2351932 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 2.30e-10 | 7 | 226 | 5 | 1731192 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 1627536 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 2.30e-10 | 7 | 226 | 5 | 2422118 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 34181639 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 15809355 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 2.30e-10 | 7 | 226 | 5 | 3840195 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 2.30e-10 | 7 | 226 | 5 | 11894934 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 19700752 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 11894963 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 22287714 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 2997361 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 9869916 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 312902 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 3335396 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 6689056 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 16461341 | ||
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 6895187 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 2.30e-10 | 7 | 226 | 5 | 6822218 | |
| Pubmed | 2.30e-10 | 7 | 226 | 5 | 15210799 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 2.30e-10 | 7 | 226 | 5 | 19820922 | |
| Interaction | B2M interactions | HLA-A HLA-B HLA-C HLA-G CHRM4 TAP1 RGPD5 KPNA4 RANBP2 CD1D HERC5 | 5.83e-09 | 92 | 223 | 11 | int:B2M |
| Interaction | RGPD1 interactions | 1.07e-06 | 49 | 223 | 7 | int:RGPD1 | |
| Interaction | CANX interactions | ADGRG5 CALR3 MAN2A1 HLA-A HLA-B HLA-C PDGFRA ACP2 LRRK2 NRROS SORT1 SPTBN5 PCYOX1L RINT1 RAB3GAP2 JAG1 C1QBP IL17RA TAP1 NUP160 KPNA4 AMFR TAPT1 ST3GAL1 NHLRC3 NUDCD2 LDLR CCNF CD1D IGF1R IGF2R ICMT LNPEP LRP1 | 1.29e-06 | 1261 | 223 | 34 | int:CANX |
| Interaction | LILRB1 interactions | 2.91e-06 | 10 | 223 | 4 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 2.91e-06 | 10 | 223 | 4 | int:LILRB2 | |
| Interaction | RGPD4 interactions | 3.58e-06 | 22 | 223 | 5 | int:RGPD4 | |
| Interaction | HSD3B7 interactions | HLA-A HLA-C RINT1 FDFT1 RAB3GAP2 SYNE2 KRT40 VPS13A TAP1 NUP160 KPNA4 NUP98 ANO10 IGF2R ICMT LNPEP | 6.76e-06 | 386 | 223 | 16 | int:HSD3B7 |
| Interaction | CD8A interactions | 8.63e-06 | 26 | 223 | 5 | int:CD8A | |
| Interaction | RGPD2 interactions | 1.05e-05 | 27 | 223 | 5 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 1.26e-05 | 47 | 223 | 6 | int:RGPD3 | |
| Interaction | PLK1 interactions | RGPD4 ORC3 STK26 LRRK2 BCR FZR1 INTS11 HECTD1 DNHD1 RANBP2 DYNC2I1 ODF2 LDLR MAD2L1BP CCNF SF3B3 MAPK6 CDC20 | 1.62e-05 | 510 | 223 | 18 | int:PLK1 |
| Interaction | RAN interactions | RGPD4 FZR1 AGL RGPD3 RAB4A KPNA1 RGPD5 KPNA4 RANBP2 RGPD8 LARS1 NUP98 CCNF IPO13 HCFC1 HERC5 XPOT | 2.34e-05 | 475 | 223 | 17 | int:RAN |
| Interaction | CDC42 interactions | EPHB4 RALGAPA1 PDE6C HLA-A HLA-B HLA-C LRRK2 HLA-G FKBP9 SH3GLB2 ARHGEF11 BCR NF1 SYNE2 VPS13A ARHGAP29 C1QBP UTP20 CORO7 TAP1 RAB4A KPNA1 IRS4 SYNE1 LARS1 FRYL CCNF THADA IGF2R LNPEP MAPK6 XPOT | 2.49e-05 | 1323 | 223 | 32 | int:CDC42 |
| Interaction | HLA-E interactions | 2.73e-05 | 79 | 223 | 7 | int:HLA-E | |
| Interaction | NUP153 interactions | FZR1 C1QBP NUP160 KPNA1 KPNA4 RANBP2 RGPD8 NUP98 CCNF HERC5 XPOT | 3.03e-05 | 216 | 223 | 11 | int:NUP153 |
| Interaction | HLA-H interactions | 3.10e-05 | 17 | 223 | 4 | int:HLA-H | |
| Interaction | TOP3B interactions | EPHB4 EPPK1 IRS1 PLXND1 ARID1A ARHGEF11 BCR CHRM4 FZR1 SSH1 SCN5A INTS11 PKD1 C1QBP WDR90 HECTD1 ZNF426 HOXB13 THOC1 WWP1 LARS1 TBC1D25 ST3GAL1 FRYL IDUA LDLR CCNF THADA IGF1R IGF2R MROH6 IL4R HCFC1 DDX28 | 3.37e-05 | 1470 | 223 | 34 | int:TOP3B |
| Interaction | TMT1A interactions | HLA-A HLA-C CCDC168 RINT1 FDFT1 RAB3GAP2 SYNE2 VPS13A NUP160 SYNE1 NUP98 ANO10 IGF2R LNPEP | 5.00e-05 | 359 | 223 | 14 | int:TMT1A |
| Interaction | RANBP2 interactions | RGPD4 ILF2 RGPD3 NUP160 KPNA1 RGPD5 KPNA4 RANBP2 COL17A1 RGPD8 NUP98 MAU2 CCNF XPOT | 5.31e-05 | 361 | 223 | 14 | int:RANBP2 |
| Interaction | STX4 interactions | HLA-A HLA-C SH3GLB2 RINT1 RAB3GAP2 SYNE2 VPS13A HECTD1 RAB4A IRS4 SYNE1 LARS1 MB21D2 IGF2R LNPEP | 9.00e-05 | 428 | 223 | 15 | int:STX4 |
| Interaction | RHOC interactions | EPHB4 HLA-A HLA-B HLA-C MFSD6 ARHGEF11 BCR TRIM59 FZR1 JAG1 SYNE2 VPS13A C1QBP UTP20 KPNA1 CMIP IGF2R LNPEP | 9.35e-05 | 584 | 223 | 18 | int:RHOC |
| Interaction | CKAP4 interactions | EPHB4 CALR3 HLA-C PDGFRA FZR1 RINT1 RAB3GAP2 SYNE2 ARHGAP29 HECTD1 RAB4A AMFR TAPT1 NUP98 CCDC80 CCNF IGF1R IGF2R | 1.11e-04 | 592 | 223 | 18 | int:CKAP4 |
| Interaction | CTDSPL2 interactions | 1.25e-04 | 70 | 223 | 6 | int:CTDSPL2 | |
| Interaction | RAC1 interactions | EPHB4 RALGAPA1 HLA-A HLA-B HLA-C ITGB1BP1 LRRK2 ARHGEF11 BCR NF1 FDFT1 JAG1 KRT40 VPS13A C1QBP UTP20 NUP160 KPNA1 KPNA4 IRS4 CMIP IGF2R ICMT LNPEP DDX28 XPOT | 1.28e-04 | 1063 | 223 | 26 | int:RAC1 |
| GeneFamily | WD repeat domain containing | WDR3 FZR1 PRPF19 WDR90 TAF5 CORO7 WDR13 DMXL2 WDR5B DYNC2I1 WDR37 CDC20 | 1.58e-06 | 262 | 147 | 12 | 362 |
| GeneFamily | Cholinergic receptors muscarinic | 5.20e-06 | 5 | 147 | 3 | 180 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.17e-05 | 18 | 147 | 4 | 596 | |
| GeneFamily | C1-set domain containing | 2.22e-05 | 42 | 147 | 5 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 2.79e-05 | 44 | 147 | 5 | 588 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.29e-05 | 115 | 147 | 7 | 769 | |
| GeneFamily | AT-rich interaction domain containing | 2.23e-04 | 15 | 147 | 3 | 418 | |
| GeneFamily | Aminopeptidases|CD molecules | 3.29e-04 | 17 | 147 | 3 | 104 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.90e-04 | 4 | 147 | 2 | 1252 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.05e-04 | 43 | 147 | 4 | 409 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.45e-03 | 394 | 147 | 10 | 471 | |
| GeneFamily | Nucleoporins | 2.20e-03 | 32 | 147 | 3 | 1051 | |
| GeneFamily | Cyclins|F-boxes other | 3.88e-03 | 39 | 147 | 3 | 560 | |
| GeneFamily | Low density lipoprotein receptors | 4.83e-03 | 13 | 147 | 2 | 634 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | EPHB4 EPPK1 HLA-A HLA-B HLA-C HLA-G HLA-H ARID1A FZR1 SSH1 IL17RA COL4A1 TMPPE TAPT1 TBC1D25 ANO10 CLDN12 LDLR IGF1R SF3B3 ICMT LRP1 CDC20 IL4R XPOT | 2.06e-09 | 703 | 224 | 25 | MM1055 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 9.01e-09 | 19 | 224 | 6 | MM862 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | EPHB4 CYP4F8 EPPK1 HLA-A HLA-B ARID1A FZR1 SSH1 IL17RA COL4A1 TMPPE TAPT1 TBC1D25 ANO10 CLDN12 LDLR IGF1R SF3B3 ICMT LRP1 CDC20 IL4R XPOT | 2.45e-08 | 681 | 224 | 23 | M5314 |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | STK26 MFSD6 ARHGAP29 IL17RA SEMA4A WDR13 THEMIS SYNE1 SETD4 ST3GAL1 LDLR PIK3R5 | 1.60e-07 | 199 | 224 | 12 | M5729 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 1.76e-07 | 16 | 224 | 5 | MM3766 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | ADGRG5 HLA-A HLA-B HLA-C PDGFRA LRRK2 HLA-G HLA-H INTS11 VPS13A SYBU LRP1 | 3.00e-07 | 211 | 224 | 12 | MM17081 |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 4.60e-07 | 19 | 224 | 5 | MM797 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 6.09e-07 | 20 | 224 | 5 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 7.93e-07 | 21 | 224 | 5 | MM651 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 8.97e-07 | 88 | 224 | 8 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 9.39e-07 | 39 | 224 | 6 | MM3725 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_UP | MFSD6 ARHGAP29 IL17RA SEMA4A WDR13 THEMIS SYNE1 SETD4 ST3GAL1 LDLR PIK3R5 | 1.31e-06 | 200 | 224 | 11 | M5673 |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | ADGRG5 HLA-A HLA-B HLA-C HLA-G HLA-H PKD1L2 NRROS ITGAL IL17RA CORO7 TAP1 THEMIS WWP1 NHLRC3 PSTPIP2 REPS2 PIK3R5 IL4R | 1.61e-06 | 615 | 224 | 19 | MM3641 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 1.62e-06 | 24 | 224 | 5 | MM3773 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 1.71e-06 | 43 | 224 | 6 | MM1204 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.01e-06 | 25 | 224 | 5 | MM672 | |
| Coexpression | DURAND_STROMA_S_UP | RALGAPA1 PDGFRA PLXND1 PTX3 DCLK2 HOXB13 NID2 DYNC2I1 CCDC80 ST3GAL1 DEPDC7 IL4R PYGO1 | 2.09e-06 | 300 | 224 | 13 | M2581 |
| Coexpression | DURAND_STROMA_S_UP | RALGAPA1 PDGFRA PLXND1 PTX3 DCLK2 HOXB13 NID2 DYNC2I1 CCDC80 ST3GAL1 DEPDC7 IL4R PYGO1 | 2.41e-06 | 304 | 224 | 13 | MM1083 |
| Coexpression | BAUS_TFF2_TARGETS_UP | 3.75e-06 | 49 | 224 | 6 | MM1287 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAN2A1 STAG1 IRS1 DCUN1D4 PTX3 SYNE2 VPS13A ARHGAP29 UTP20 BCAR3 NUP160 RANBP2 DMXL2 ARID4A WWP1 NUP98 FRYL WDR37 LDLR IGF1R IGF2R MAPK6 | 4.80e-06 | 856 | 224 | 22 | M4500 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | CYP4F8 GALC HLA-A HLA-B HLA-C HLA-G HLA-H SYNE2 CCNF CD1D HAAO CYP4F12 ENPEP | 5.89e-06 | 330 | 224 | 13 | MM1120 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 6.18e-06 | 31 | 224 | 5 | MM3729 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 9.28e-06 | 120 | 224 | 8 | MM3710 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 1.12e-05 | 59 | 224 | 6 | MM3704 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 1.15e-05 | 35 | 224 | 5 | MM674 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 1.21e-05 | 6 | 224 | 3 | M7182 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | EPHB4 HLA-A HLA-B HLA-C PDGFRA HLA-G HLA-H PKD1 COL4A1 TMPPE NHLRC3 LDLR IGF1R SF3B3 LRP1 | 1.42e-05 | 470 | 224 | 15 | MM1053 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.98e-05 | 39 | 224 | 5 | MM3758 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 2.54e-05 | 41 | 224 | 5 | MM710 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | HLA-A HLA-B HLA-C ITGB1BP1 HLA-G HLA-H AMMECR1L TAF5 KLHL33 NUP160 KPNA4 RALGDS DYNC2I1 CCDC80 FRYL NHLRC3 PSTPIP2 ZNF692 ICMT CAPRIN2 LRP1 FAM98C | 2.56e-05 | 954 | 224 | 22 | MM3689 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 2.85e-05 | 140 | 224 | 8 | M617 | |
| Coexpression | LIN_NPAS4_TARGETS_UP | 2.97e-05 | 183 | 224 | 9 | MM767 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 3.61e-05 | 44 | 224 | 5 | MM3775 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 3.61e-05 | 44 | 224 | 5 | MM805 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 3.85e-05 | 73 | 224 | 6 | M11428 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 3.85e-05 | 146 | 224 | 8 | MM964 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 4.49e-05 | 46 | 224 | 5 | MM3712 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 5.94e-05 | 200 | 224 | 9 | M8088 | |
| Coexpression | PEREZ_TP63_TARGETS | EPPK1 HUNK ARID1B PTX3 JAG1 SYNE2 TAF5 ABHD16A ST3GAL1 FRYL IGF1R MROH6 | 6.17e-05 | 356 | 224 | 12 | M10761 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 6.75e-05 | 50 | 224 | 5 | MM3805 | |
| Coexpression | PILON_KLF1_TARGETS_UP | HLA-B HLA-C HLA-G HLA-H ARHGAP29 HECTD1 KPNA1 COL4A1 NID2 FRYL WDR37 IGF1R AOPEP SERPINA10 REPS2 | 7.10e-05 | 541 | 224 | 15 | MM1061 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 7.42e-05 | 82 | 224 | 6 | MM3858 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 8.17e-05 | 52 | 224 | 5 | MM3808 | |
| Coexpression | LEE_BMP2_TARGETS_DN | TBRG4 ILF2 TRIM59 ACOD1 WDR3 PTX3 INTS11 C1QBP UTP20 TAF5 NUP160 KPNA1 KPNA4 SLF1 NUDCD2 LDLR MB21D2 SF3B3 MAPK6 XPOT | 1.06e-04 | 904 | 224 | 20 | M2325 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.17e-04 | 56 | 224 | 5 | MM3852 | |
| Coexpression | KIM_LRRC3B_TARGETS | 1.20e-04 | 30 | 224 | 4 | M17363 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 1.25e-04 | 90 | 224 | 6 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 1.27e-04 | 57 | 224 | 5 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 1.33e-04 | 91 | 224 | 6 | MM3720 | |
| Coexpression | LEE_BMP2_TARGETS_DN | TBRG4 ILF2 TRIM59 ACOD1 WDR3 PTX3 INTS11 C1QBP UTP20 TAF5 NUP160 KPNA1 KPNA4 SLF1 NUDCD2 LDLR MB21D2 SF3B3 MAPK6 XPOT | 1.38e-04 | 922 | 224 | 20 | MM1068 |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 1.45e-04 | 132 | 224 | 7 | MM841 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 1.50e-04 | 59 | 224 | 5 | MM3688 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.75e-04 | 33 | 224 | 4 | MM477 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 1.99e-04 | 98 | 224 | 6 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 2.23e-04 | 100 | 224 | 6 | MM458 | |
| Coexpression | SU_KIDNEY | 2.60e-04 | 15 | 224 | 3 | M5672 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 2.61e-04 | 103 | 224 | 6 | MM476 | |
| Coexpression | FISCHER_DREAM_TARGETS | TBRG4 STAG1 ORC3 TRIM59 UBE2R2 FZR1 BCAR3 TAF5 NUP160 THOC1 SLF1 NUP98 ODF2 NUDCD2 FIGN LDLR CCNF SF3B3 CDC20 HCFC1 | 2.65e-04 | 969 | 224 | 20 | M149 |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 2.69e-04 | 146 | 224 | 7 | MM856 | |
| Coexpression | YU_MYC_TARGETS_DN | 2.93e-04 | 68 | 224 | 5 | MM632 | |
| Coexpression | EGFR_UP.V1_DN | 2.97e-04 | 196 | 224 | 8 | M2633 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BASOPHIL_UP | 2.97e-04 | 196 | 224 | 8 | M5413 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC | 3.05e-04 | 106 | 224 | 6 | M15801 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | 3.07e-04 | 197 | 224 | 8 | M9580 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_UP | 3.07e-04 | 197 | 224 | 8 | M5596 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 3.29e-04 | 199 | 224 | 8 | M9410 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 3.29e-04 | 199 | 224 | 8 | M9414 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 3.29e-04 | 199 | 224 | 8 | M9568 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN | 3.29e-04 | 199 | 224 | 8 | M9970 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_DN | 3.40e-04 | 200 | 224 | 8 | M7293 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN | 3.40e-04 | 200 | 224 | 8 | M7230 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP | 3.40e-04 | 200 | 224 | 8 | M8596 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 3.40e-04 | 200 | 224 | 8 | M7505 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 3.40e-04 | 200 | 224 | 8 | M6243 | |
| Coexpression | GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN | 3.40e-04 | 200 | 224 | 8 | M6781 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | MAN2A1 MFSD6 PLXND1 ARID1A CHRM2 CHRM3 SYNE2 RAB4A NUP160 HOXB13 AMFR SLF1 TAPT1 ST3GAL1 WDR37 BTBD3 SLC35F5 MAPK6 | 3.72e-04 | 845 | 224 | 18 | M18090 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 3.73e-04 | 40 | 224 | 4 | M41037 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 4.02e-04 | 156 | 224 | 7 | MM3763 | |
| Coexpression | ONO_FOXP3_TARGETS_DN | 4.10e-04 | 41 | 224 | 4 | M1982 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 4.35e-04 | 74 | 224 | 5 | MM3796 | |
| Coexpression | ZHAN_EARLY_DIFFERENTIATION_GENES_DN | 4.51e-04 | 42 | 224 | 4 | M1476 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 HLA-A HLA-B HLA-C ITGB1BP1 HLA-H METTL23 ARID1A ITGAL SSH1 RAB3GAP2 IL17RA TAP1 KPNA4 RALGDS RANBP2 THEMIS SLF1 ARID4A SYNE1 NUP98 ST3GAL1 FRYL SF3B3 LNPEP PIK3R5 | 4.58e-04 | 1492 | 224 | 26 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 4.63e-04 | 75 | 224 | 5 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 4.63e-04 | 75 | 224 | 5 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.93e-04 | 43 | 224 | 4 | MM3857 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | HLA-A MFSD6 HLA-G FZR1 RAB4B SSH1 JAG1 PKD1 C1QBP UTP20 SEMA4A TAP1 NUP160 TAPT1 ARID4A ST3GAL1 NHLRC3 IGF2R LNPEP | 5.01e-04 | 942 | 224 | 19 | M8144 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 5.13e-04 | 267 | 224 | 9 | MM1091 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_UROTHELIAL_CELL_AGEING | 5.42e-04 | 164 | 224 | 7 | MM3680 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-07 | 157 | 226 | 9 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-07 | 188 | 226 | 9 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.90e-07 | 194 | 226 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.85e-07 | 197 | 226 | 9 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.85e-07 | 197 | 226 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-07 | 199 | 226 | 9 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.90e-07 | 200 | 226 | 9 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.90e-07 | 200 | 226 | 9 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.90e-07 | 200 | 226 | 9 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-06 | 157 | 226 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_CTL|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.82e-06 | 162 | 226 | 8 | d53de64df2511eddba79f899fc3f48b1b059923f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-06 | 171 | 226 | 8 | d6d8ea45b443d95f64720c9bc07d324148f5b239 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 3.82e-06 | 179 | 226 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 4.69e-06 | 184 | 226 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.28e-06 | 187 | 226 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.49e-06 | 188 | 226 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.41e-06 | 192 | 226 | 8 | 0f8c63de26128694f4522f9f6d029e4628c890bc | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.41e-06 | 192 | 226 | 8 | 01d01c9293f2439dc4c34c648273319c9beee5c7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.65e-06 | 193 | 226 | 8 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.65e-06 | 193 | 226 | 8 | c1d9c2436503791350086a503d6b98c5c69f44ae | |
| ToppCell | IIH-CD8-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 6.65e-06 | 193 | 226 | 8 | c5a4926003906d6726155f19061b73fb45d9962c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 193 | 226 | 8 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | IIH-CD8|IIH / Condition, Cell_class and T cell subcluster | 6.65e-06 | 193 | 226 | 8 | 343ac8c6dc6d7c7a944a14de65f1d4ea3dfafe86 | |
| ToppCell | COVID-CD8-CD8_1|COVID / Condition, Cell_class and T cell subcluster | 6.65e-06 | 193 | 226 | 8 | 221690901cb214c8ee186ff527c80dcc52d1fb1c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.91e-06 | 194 | 226 | 8 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | BLOOD--(1)_EM_CTLs| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.91e-06 | 194 | 226 | 8 | 66583c6cff3814902d6babdea3a2ae962decde65 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.18e-06 | 195 | 226 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 7.18e-06 | 195 | 226 | 8 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.18e-06 | 195 | 226 | 8 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 7.18e-06 | 195 | 226 | 8 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 7.18e-06 | 195 | 226 | 8 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.18e-06 | 195 | 226 | 8 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.45e-06 | 196 | 226 | 8 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.45e-06 | 196 | 226 | 8 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.45e-06 | 196 | 226 | 8 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.45e-06 | 196 | 226 | 8 | d83acd9abd7b296989b8ae09da63799e6877a149 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.45e-06 | 196 | 226 | 8 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.45e-06 | 196 | 226 | 8 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 7.73e-06 | 197 | 226 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.73e-06 | 197 | 226 | 8 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-06 | 197 | 226 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-06 | 197 | 226 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-06 | 197 | 226 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-06 | 197 | 226 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-CD8|COVID / Condition, Cell_class and T cell subcluster | 7.73e-06 | 197 | 226 | 8 | 4c61ea7eba706bdc7345745941ae8b9f6a21e844 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.02e-06 | 198 | 226 | 8 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.32e-06 | 199 | 226 | 8 | 598937913fe1f12d741fa49e23ae195a7be5cbe3 | |
| ToppCell | VE-CD8|VE / Condition, Cell_class and T cell subcluster | 8.32e-06 | 199 | 226 | 8 | 9ae4d3e93b6e0861258e567c901ec34f04ded547 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-06 | 199 | 226 | 8 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.32e-06 | 199 | 226 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.32e-06 | 199 | 226 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.32e-06 | 199 | 226 | 8 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.63e-06 | 200 | 226 | 8 | 62e9ca7cf4f49fc8957740acee41a1e530f10541 | |
| ToppCell | remission-CD8+_Tem|World / disease stage, cell group and cell class | 8.63e-06 | 200 | 226 | 8 | 0ebf0dda91fc7adb9ea69734ad9dcc65d0082c6d | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.63e-06 | 200 | 226 | 8 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-06 | 200 | 226 | 8 | 16a70cc07dcfb4eba4385b712f27010c6629ff67 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_CTL|Multiple_Sclerosis / Disease, condition lineage and cell class | 8.63e-06 | 200 | 226 | 8 | 2e18ce20dc61ae90883139d1b0c29d145888c001 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-05 | 161 | 226 | 7 | 39030380e04f57f8e7de231577ec3177e1b6490d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Adora1_(Striatum,_interneuron)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 66 | 226 | 5 | d6b202d9f5bebaac23b34b689ad306549dec0593 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Adora1_(Striatum,_interneuron)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 66 | 226 | 5 | 4a714cf035b22da103054098f85f9170c56e9e83 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 165 | 226 | 7 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-05 | 169 | 226 | 7 | e3100eb587005e160bd0b7990fa57ec49765133d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1-Excitatory_Neuron.Slc17a7.Parm1.Cadm2_(Deep_layer_pyramidal_cells--layer_5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.55e-05 | 34 | 226 | 4 | c217c09c1d7e84f14b9e0d1e7c6e8e916b3c7d10 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 171 | 226 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 171 | 226 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.74e-05 | 171 | 226 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-05 | 174 | 226 | 7 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.18e-05 | 175 | 226 | 7 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 120 | 226 | 6 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-05 | 178 | 226 | 7 | 375c9449be570b4aed83611f9c6fe1665e677818 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.94e-05 | 181 | 226 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 4.08e-05 | 182 | 226 | 7 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 4.22e-05 | 183 | 226 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-05 | 183 | 226 | 7 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 4.22e-05 | 183 | 226 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 184 | 226 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 184 | 226 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 184 | 226 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-05 | 185 | 226 | 7 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.53e-05 | 185 | 226 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-05 | 186 | 226 | 7 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-05 | 186 | 226 | 7 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-05 | 186 | 226 | 7 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 187 | 226 | 7 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 189 | 226 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 189 | 226 | 7 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.18e-05 | 189 | 226 | 7 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.18e-05 | 189 | 226 | 7 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.18e-05 | 189 | 226 | 7 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-05 | 190 | 226 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 5.36e-05 | 190 | 226 | 7 | e1f474dc36bf9eaf457b14a8761d287904754cdc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-05 | 191 | 226 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 5.54e-05 | 191 | 226 | 7 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.72e-05 | 192 | 226 | 7 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-05 | 192 | 226 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.72e-05 | 192 | 226 | 7 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.72e-05 | 192 | 226 | 7 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-05 | 192 | 226 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-05 | 192 | 226 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.72e-05 | 192 | 226 | 7 | 71bc03b08cda0382ea45b503d5f4f135ed98cc11 | |
| Computational | Genes in the cancer module 293. | 7.53e-06 | 12 | 123 | 4 | MODULE_293 | |
| Computational | Neighborhood of HLA-C | 1.45e-05 | 47 | 123 | 6 | GNF2_HLA_C | |
| Computational | Genes in the cancer module 143. | 1.50e-05 | 14 | 123 | 4 | MODULE_143 | |
| Computational | Neighborhood of CD53 | 4.94e-05 | 58 | 123 | 6 | GNF2_CD53 | |
| Computational | Neighborhood of INPP5D | 1.23e-04 | 43 | 123 | 5 | GNF2_INPP5D | |
| Computational | Neighborhood of PTPN6 | 1.89e-04 | 47 | 123 | 5 | GNF2_PTPN6 | |
| Computational | Immune (defense) response. | 2.18e-04 | 142 | 123 | 8 | MODULE_223 | |
| Computational | Neighborhood of CD48 | 4.58e-04 | 32 | 123 | 4 | GNF2_CD48 | |
| Computational | Neighborhood of VAV1 | 7.25e-04 | 36 | 123 | 4 | GNF2_VAV1 | |
| Drug | 1-deoxynojirimycin hydrochloride | 6.81e-07 | 102 | 221 | 9 | CID000001374 | |
| Drug | Strychnine | 1.73e-06 | 10 | 221 | 4 | ctd:D013331 | |
| Drug | furtrethonium | 3.58e-06 | 4 | 221 | 3 | ctd:C028530 | |
| Drug | Hyoscyamine | 3.58e-06 | 4 | 221 | 3 | DB00424 | |
| Drug | Procyclidine | 3.58e-06 | 4 | 221 | 3 | DB00387 | |
| Drug | Disopyramide | 3.58e-06 | 4 | 221 | 3 | DB00280 | |
| Drug | Tropicamide | 3.58e-06 | 4 | 221 | 3 | DB00809 | |
| Drug | 5-methylfurtrethonium | 3.58e-06 | 4 | 221 | 3 | ctd:C008446 | |
| Drug | Atropine | 8.89e-06 | 5 | 221 | 3 | DB00572 | |
| Drug | Darifenacin | 8.89e-06 | 5 | 221 | 3 | DB00496 | |
| Drug | Metixene | 8.89e-06 | 5 | 221 | 3 | DB00340 | |
| Drug | Trihexyphenidyl | 8.89e-06 | 5 | 221 | 3 | DB00376 | |
| Drug | Solifenacin | 8.89e-06 | 5 | 221 | 3 | DB01591 | |
| Drug | 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide | 8.89e-06 | 5 | 221 | 3 | ctd:C568516 | |
| Drug | Pipecuronium | 8.89e-06 | 5 | 221 | 3 | ctd:D017300 | |
| Drug | N-Methylscopolamine | 8.89e-06 | 5 | 221 | 3 | ctd:D019832 | |
| Drug | Cryptenamine | 8.89e-06 | 5 | 221 | 3 | DB00785 | |
| Drug | Homatropine Methylbromide | 8.89e-06 | 5 | 221 | 3 | DB00725 | |
| Drug | Fesoterodine | 8.89e-06 | 5 | 221 | 3 | DB06702 | |
| Drug | Scopolamine Derivatives | 8.89e-06 | 5 | 221 | 3 | ctd:D012602 | |
| Drug | Tolterodine | 8.89e-06 | 5 | 221 | 3 | DB01036 | |
| Drug | Quinuclidinyl Benzilate | 8.89e-06 | 5 | 221 | 3 | ctd:D011813 | |
| Drug | Nsc34399 | 1.77e-05 | 6 | 221 | 3 | CID000003622 | |
| Drug | Gallamine Triethiodide | 1.77e-05 | 6 | 221 | 3 | ctd:D005703 | |
| Drug | Brompheniramine | 1.77e-05 | 6 | 221 | 3 | DB00835 | |
| Drug | Benzquinamide | 1.77e-05 | 6 | 221 | 3 | DB00767 | |
| Drug | Scopolamine | 1.77e-05 | 6 | 221 | 3 | DB00747 | |
| Drug | Crotalid Venoms | 1.77e-05 | 6 | 221 | 3 | ctd:D003435 | |
| Drug | brucine N-oxide | 1.77e-05 | 6 | 221 | 3 | ctd:C083067 | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; HL60; HT_HG-U133A | ARHGEF11 RINT1 NF1 VPS13A NUP160 KPNA1 KPNA4 WDR5B WDR37 LDLR | 2.30e-05 | 196 | 221 | 10 | 2506_DN |
| Drug | Tiotropium Bromide | 3.07e-05 | 7 | 221 | 3 | ctd:D000069447 | |
| Drug | Maprotiline | 4.87e-05 | 8 | 221 | 3 | DB00934 | |
| Drug | Paroxetine | 4.87e-05 | 8 | 221 | 3 | DB00715 | |
| Drug | oxotremorine M | 4.87e-05 | 8 | 221 | 3 | ctd:C042743 | |
| Drug | Isopropamide | 9.38e-05 | 2 | 221 | 2 | DB01625 | |
| Drug | methylitaconate | 9.38e-05 | 2 | 221 | 2 | CID000439700 | |
| Drug | caracurine | 9.38e-05 | 2 | 221 | 2 | ctd:C006890 | |
| Drug | himbacine | 9.38e-05 | 2 | 221 | 2 | ctd:C048172 | |
| Drug | NPS 1506 | 9.38e-05 | 2 | 221 | 2 | CID000156420 | |
| Drug | N-chloromethylbrucine | 9.38e-05 | 2 | 221 | 2 | ctd:C118330 | |
| Drug | Bethanechol | 1.03e-04 | 10 | 221 | 3 | ctd:D018723 | |
| Drug | Promethazine | 1.03e-04 | 10 | 221 | 3 | DB01069 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.09e-04 | 191 | 221 | 9 | 6944_DN | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 9.26e-08 | 7 | 214 | 4 | DOID:0081267 (implicated_via_orthology) | |
| Disease | platelet crit | ADGRG5 TBRG4 HLA-A STAG1 HLA-B MFSD6 LRRK2 ARID1A ARHGEF11 FBXO47 NF1 ARHGAP29 NUP160 COL4A1 HEATR4 MAU2 PSTPIP2 THADA IGF1R PRPF3 | 2.25e-05 | 952 | 214 | 20 | EFO_0007985 |
| Disease | Malignant neoplasm of breast | EPHB4 ARID1A SORCS1 ARID1B NF1 JAG1 SYNE2 ARHGAP29 C1QBP UTP20 BCAR3 HOXB13 AMFR NID2 SYNE1 NUP98 LDHAL6B IGF1R CYB5R4 REPS2 ENPEP | 3.98e-05 | 1074 | 214 | 21 | C0006142 |
| Disease | neuroblastoma (is_implicated_in) | 4.35e-05 | 10 | 214 | 3 | DOID:769 (is_implicated_in) | |
| Disease | – | 5.24e-05 | 2 | 214 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 5.24e-05 | 2 | 214 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 5.24e-05 | 2 | 214 | 2 | cv:CN077964 | |
| Disease | beta-2 microglobulin measurement | 5.95e-05 | 11 | 214 | 3 | EFO_0005197 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.08e-05 | 144 | 214 | 7 | EFO_0004611, EFO_0020943 | |
| Disease | Burkitt Lymphoma | 1.32e-04 | 36 | 214 | 4 | C0006413 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.38e-04 | 206 | 214 | 8 | EFO_0004612, EFO_0020947 | |
| Disease | Moyamoya Disease | 2.37e-04 | 17 | 214 | 3 | C0026654 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.52e-04 | 225 | 214 | 8 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.94e-04 | 291 | 214 | 9 | EFO_0008317, EFO_0020946 | |
| Disease | Corneal Opacity | 3.11e-04 | 4 | 214 | 2 | C0010038 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.11e-04 | 4 | 214 | 2 | cv:CN293514 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 3.11e-04 | 4 | 214 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | esterified cholesterol measurement | 3.53e-04 | 128 | 214 | 6 | EFO_0008589 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.77e-04 | 239 | 214 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | forced expiratory volume, response to bronchodilator | EPPK1 CHRM2 CHRM3 TRIM59 RAB4B DNAH5 KPNA4 SYNE1 BTBD3 TTC29 SERPINA10 | 4.38e-04 | 445 | 214 | 11 | EFO_0004314, GO_0097366 |
| Disease | Precursor B-cell lymphoblastic leukemia | 4.54e-04 | 21 | 214 | 3 | C1292769 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.16e-04 | 5 | 214 | 2 | C1450051 | |
| Disease | allergic asthma (is_implicated_in) | 5.16e-04 | 5 | 214 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.16e-04 | 5 | 214 | 2 | C0410190 | |
| Disease | reactive arthritis (is_implicated_in) | 5.16e-04 | 5 | 214 | 2 | DOID:6196 (is_implicated_in) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.16e-04 | 5 | 214 | 2 | C3281201 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.71e-04 | 200 | 214 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.25e-04 | 264 | 214 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | R-warfarin measurement | 7.43e-04 | 265 | 214 | 8 | EFO_0803324 | |
| Disease | Takayasu arteritis | 7.60e-04 | 148 | 214 | 6 | EFO_1001857 | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.70e-04 | 6 | 214 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.70e-04 | 6 | 214 | 2 | C0410189 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 9.22e-04 | 274 | 214 | 8 | EFO_0004530, EFO_0004612 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.02e-03 | 215 | 214 | 7 | EFO_0008317, EFO_0008591 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.03e-03 | 105 | 214 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia | 1.07e-03 | 106 | 214 | 5 | MONDO_0001336 | |
| Disease | permanent dental caries | 1.07e-03 | 7 | 214 | 2 | EFO_0600096 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.07e-03 | 7 | 214 | 2 | C0751337 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.08e-03 | 28 | 214 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | eosinophil percentage of leukocytes | HLA-A HLA-B HLA-C CYP27B1 HLA-G NRROS TRIM59 RAB4B IL17RA THADA CMIP PIK3R5 IL4R MASP2 | 1.17e-03 | 746 | 214 | 14 | EFO_0007991 |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.20e-03 | 29 | 214 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.20e-03 | 29 | 214 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.20e-03 | 29 | 214 | 3 | C3658302 | |
| Disease | 1,5 anhydroglucitol measurement | 1.20e-03 | 29 | 214 | 3 | EFO_0008009 | |
| Disease | Toxic Epidermal Necrolysis | 1.20e-03 | 29 | 214 | 3 | C0014518 | |
| Disease | serum IgE measurement | 1.22e-03 | 64 | 214 | 4 | EFO_0004579 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.23e-03 | 222 | 214 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | Coronary Arteriosclerosis | 1.29e-03 | 65 | 214 | 4 | C0010054 | |
| Disease | Coronary Artery Disease | 1.29e-03 | 65 | 214 | 4 | C1956346 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.30e-03 | 224 | 214 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.30e-03 | 224 | 214 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | Stevens-Johnson Syndrome | 1.32e-03 | 30 | 214 | 3 | C0038325 | |
| Disease | hypertension (biomarker_via_orthology) | 1.40e-03 | 227 | 214 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | coiled-coil domain-containing protein 80 measurement | 1.42e-03 | 8 | 214 | 2 | EFO_0020268 | |
| Disease | free cholesterol measurement | 1.43e-03 | 113 | 214 | 5 | EFO_0008591 | |
| Disease | hemoglobin A1 measurement | PLXND1 DCUN1D4 TRIM59 FZR1 KL JAG1 SYNE2 VPS13A MGAM THADA CMIP | 1.55e-03 | 520 | 214 | 11 | EFO_0007629 |
| Disease | congenital heart disease (implicated_via_orthology) | 1.61e-03 | 69 | 214 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | GALC PDGFRA MYOC NRROS ITGAL BCR TRIM59 AGL COL4A1 NID2 XPNPEP2 IGF2R DEPDC7 ENPEP | 1.65e-03 | 774 | 214 | 14 | C0023893 |
| Disease | Malignant Glioma | 1.70e-03 | 70 | 214 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.70e-03 | 70 | 214 | 4 | C0259783 | |
| Disease | sensory perception of sound | 1.82e-03 | 9 | 214 | 2 | GO_0007605 | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.82e-03 | 9 | 214 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | Epstein Barr viral capsid antigen seropositivity | 1.82e-03 | 9 | 214 | 2 | EFO_0009272 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.93e-03 | 121 | 214 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | Breast Carcinoma | EPHB4 ARID1A ARID1B JAG1 C1QBP BCAR3 HOXB13 SYNE1 LDHAL6B IGF1R REPS2 | 2.02e-03 | 538 | 214 | 11 | C0678222 |
| Disease | Major Depressive Disorder | 2.06e-03 | 243 | 214 | 7 | C1269683 | |
| Disease | osteoarthritis (is_marker_for) | 2.07e-03 | 35 | 214 | 3 | DOID:8398 (is_marker_for) | |
| Disease | heel bone mineral density, urate measurement | 2.19e-03 | 182 | 214 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | hippocampal CA3 volume | 2.25e-03 | 36 | 214 | 3 | EFO_0009395 | |
| Disease | Abnormality of nervous system morphology | 2.27e-03 | 10 | 214 | 2 | C4022810 | |
| Disease | triacylglycerol 54:1 measurement | 2.27e-03 | 10 | 214 | 2 | EFO_0010419 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 2.30e-03 | 126 | 214 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.38e-03 | 127 | 214 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | Lung diseases | 2.52e-03 | 78 | 214 | 4 | C0024115 | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 2.76e-03 | 11 | 214 | 2 | EFO_0801494 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 2.76e-03 | 11 | 214 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | sleep disorder (implicated_via_orthology) | 2.76e-03 | 11 | 214 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | cholesteryl ester measurement | 2.82e-03 | 257 | 214 | 7 | EFO_0010351 | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 2.84e-03 | 39 | 214 | 3 | DOID:526 (is_implicated_in) | |
| Disease | skin microbiome measurement | 2.84e-03 | 39 | 214 | 3 | EFO_0801228 | |
| Disease | Unipolar Depression | 2.94e-03 | 259 | 214 | 7 | C0041696 | |
| Disease | IGF-1 measurement | STAG1 ARID1A SYNE2 NUP98 SETD4 ST3GAL1 CMIP IGF2R AOPEP IL4R | 3.14e-03 | 488 | 214 | 10 | EFO_0004627 |
| Disease | open-angle glaucoma (is_implicated_in) | 3.29e-03 | 12 | 214 | 2 | DOID:1067 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.29e-03 | 12 | 214 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 3.29e-03 | 12 | 214 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.29e-03 | 12 | 214 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia (implicated_via_orthology) | 3.29e-03 | 12 | 214 | 2 | DOID:1168 (implicated_via_orthology) | |
| Disease | parental longevity | HLA-A HLA-B HLA-C PKD1L2 SORCS1 FZR1 VPS13A COL4A1 LDLR IGF2R | 3.43e-03 | 494 | 214 | 10 | EFO_0007796 |
| Disease | apolipoprotein B measurement | STAG1 HLA-B HLA-G ARID1A SORT1 NF1 SYNE2 LDLR THADA CMIP IGF2R SERPINA10 | 3.47e-03 | 663 | 214 | 12 | EFO_0004615 |
| Disease | feeling nervous measurement | 3.74e-03 | 87 | 214 | 4 | EFO_0009597 | |
| Disease | Glioma | 3.74e-03 | 87 | 214 | 4 | C0017638 | |
| Disease | triglycerides in large LDL measurement | 3.75e-03 | 43 | 214 | 3 | EFO_0022319 | |
| Disease | complex trait | 3.77e-03 | 271 | 214 | 7 | EFO_0010578 | |
| Disease | Coffin-Siris syndrome | 3.87e-03 | 13 | 214 | 2 | C0265338 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 3.87e-03 | 13 | 214 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Migraine Disorders | 3.87e-03 | 13 | 214 | 2 | C0149931 | |
| Disease | Hypercalcemia | 3.87e-03 | 13 | 214 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 3.87e-03 | 13 | 214 | 2 | C0026141 | |
| Disease | leukemia (is_implicated_in) | 3.87e-03 | 13 | 214 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | nephroblastoma (is_implicated_in) | 4.50e-03 | 14 | 214 | 2 | DOID:2154 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLWLALDYVVSNASV | 106 | P08173 | |
| NVWSSISVEDLSSYL | 1191 | Q9UMD9 | |
| TINLDLSNYDEDGAW | 261 | Q92564 | |
| VELGLSNYASWEVAE | 166 | O43488 | |
| NVLAVALDNSVYLWS | 196 | Q12834 | |
| ALDNSVYLWSASSGD | 201 | Q12834 | |
| SLLTNFEDASDYLDW | 196 | Q6DCA0 | |
| QEAIISKLTDASWYT | 76 | P29374 | |
| SSSLWLDFITDAENT | 1181 | Q7Z408 | |
| IESGSIEYDWNLTSL | 191 | Q96L12 | |
| DTNYTLNTDSLDWAL | 221 | Q07021 | |
| DDSLLVLAGTSYAWE | 251 | P46952 | |
| ELLLSSEDLRSHAWY | 141 | O75815 | |
| WVLSGILASEETYLS | 501 | P11274 | |
| FLNDSEWELLSVSST | 201 | O95264 | |
| EWELLSVSSTYSILQ | 206 | O95264 | |
| ASSQLEEASIYSRWE | 476 | O95870 | |
| CDLWLAIDYVASNAS | 141 | P20309 | |
| IYELVALTSSDKNTW | 1056 | O15085 | |
| YSAIEDVQLLSWENA | 111 | Q8IY22 | |
| SEEFWYNSTLTLAEA | 1671 | Q8IYW2 | |
| TLNETNDIFLWYTAA | 341 | Q9Y2F9 | |
| CDLWLALDYVVSNAS | 96 | P08172 | |
| STWALDTINILLYDD | 1721 | Q8NFD5 | |
| ELSVENIYQDWLESS | 641 | Q8N6M6 | |
| ELDVTSLLACQSYIW | 2686 | Q8TDJ6 | |
| LSLLSSESEQYQWDG | 3511 | Q96M86 | |
| AYSDSQEDEWLSAAI | 256 | Q96QD5 | |
| LLVISAPNDEDWAYS | 781 | Q76M96 | |
| ANAYSFWLATIERSE | 1626 | P02462 | |
| SDWRATNTDLLLAYA | 226 | P49792 | |
| WSADILSTIGYDNII | 11 | Q9H939 | |
| DELFLYWLSEASTQR | 16 | Q9Y5P8 | |
| TSRETYNALTNWLTD | 96 | P20338 | |
| TSRETYNSLAAWLTD | 91 | P61018 | |
| SDWQATNTDLLLAYA | 226 | Q99666 | |
| SDWRATNTDLLLAYA | 226 | O14715 | |
| DYIALNEDLRSWTAA | 146 | P01893 | |
| INEWLLSTYGSSVEI | 196 | Q13606 | |
| LHENSGSEWTSVLLY | 346 | Q9NW15 | |
| WALDTINILLYDDNS | 1686 | O14497 | |
| TVSNTLSWALYELSR | 321 | O15528 | |
| EATAALYNQDLSWLE | 466 | Q9NRD9 | |
| DYLALNEDLRSWTAA | 146 | P17693 | |
| SIFDNLYTTLSDVWS | 866 | P16234 | |
| ALTDSWEALSLDTEY | 871 | Q9H2M9 | |
| EVSWGAVATADSYLL | 381 | P51610 | |
| ASAQLWRTSTDYLLT | 241 | Q08AI8 | |
| LVLDSALDRENVWAY | 406 | Q9Y5I1 | |
| QYAWANDDISALTAS | 51 | Q5HY92 | |
| IEWTLQTDASILYLE | 96 | Q96F46 | |
| SLIQDWETSGLVYLD | 1681 | P52948 | |
| EVLSDACWALSYLTD | 256 | A9QM74 | |
| DLLSFEAYELRTDSW | 431 | A6NCF5 | |
| INTYWGLLDSEDSRL | 386 | Q6A162 | |
| FSYLNLDTTEWTTLV | 286 | Q9Y5Z7 | |
| AEVLSSAAVPDLEWY | 6 | Q15013 | |
| DWFYDSISIVLSEIQ | 186 | Q8IYB1 | |
| WDTANTISETAYEIS | 691 | Q16706 | |
| YESDADTATALTPAW | 116 | P54760 | |
| TSLLESEYAADPWVQ | 101 | Q8WVJ2 | |
| VLLVSWTYQDEELGS | 571 | Q5TA45 | |
| WTYQDEELGSFLTSL | 576 | Q5TA45 | |
| STDFDLLWYLENLSD | 6 | P59045 | |
| ALDFHLSQSALYWTD | 1301 | Q07954 | |
| DIDLLLGEAYTVEWS | 941 | O43451 | |
| GSDSLEYAWLIDVQA | 906 | Q2LD37 | |
| EYAWLIDVQAGSLTA | 911 | Q2LD37 | |
| DEWKVNLYNTLDSSI | 4526 | Q2LD37 | |
| YWDNITDSAKELISQ | 616 | Q8N568 | |
| LVQDDTSNIYIWDLL | 971 | Q8WVS4 | |
| LSWQYLTTLSQVTED | 396 | P37268 | |
| ASSSYDLTVRIWDLQ | 611 | P57737 | |
| NADLCYLSTVDWSLI | 146 | P08069 | |
| YLSTVDWSLILDAVS | 151 | P08069 | |
| DWSLILDAVSNNYIV | 156 | P08069 | |
| DYIALNEDLRSWTAA | 146 | P10321 | |
| DQLFYLNALEWAASS | 441 | Q8NBM8 | |
| VDLEWFASSTQSYIL | 1606 | Q9Y4D7 | |
| YTSWAIGLSVADLTE | 296 | Q9BYZ2 | |
| NLAQLEALYQSSWDS | 581 | Q16659 | |
| YSDWLINNSIAELVA | 466 | Q9HCR9 | |
| TQFLGWSLLNTDTYD | 426 | P51160 | |
| ATIFWIAASLLESDY | 2001 | O94915 | |
| SSSTVNWLGYILDDH | 406 | Q9NUL7 | |
| LAVDEAGLWVIYSTD | 381 | Q99972 | |
| QISILDLSEKAYLWS | 1231 | Q5S007 | |
| RTVSLWSYINSQLED | 536 | Q13614 | |
| YASIQSDDLWDSFNE | 581 | Q9UIQ6 | |
| TYQVRSADWSLEALL | 131 | Q86XA0 | |
| QSSWEEGVLADLALY | 101 | A6NGR9 | |
| YEVATWDSIATALSL | 631 | Q07075 | |
| AADSEAEQDSWYQAL | 96 | P35568 | |
| TFLYWHLEDLNGTTT | 466 | Q6ZSS7 | |
| DYIALNEDLRSWTAA | 146 | P01889 | |
| YLFDNTWLDALTRAV | 2121 | Q7Z442 | |
| DQSSLVLEEYWATLQ | 521 | Q9UII4 | |
| VLEEYWATLQESTFS | 526 | Q9UII4 | |
| YWTDSVLDKIESALL | 1201 | Q14112 | |
| TDLTLETVWNVYDTL | 196 | P11117 | |
| LLSSSDDQYWAFSDI | 321 | Q9UMS4 | |
| YLATAADDSSVKLWD | 406 | Q9UMS4 | |
| YNASLLDGTLLDSTW | 396 | O95302 | |
| NTDSIELALSYAKTW | 201 | Q52LW3 | |
| SDWRATNTDLLLAYA | 226 | A6NKT7 | |
| DDFYLNLVDWSSLNV | 186 | Q9UM11 | |
| YIWSDAAALELSNGS | 676 | Q9ULT8 | |
| SETKSILYLSQEELW | 166 | Q9BXS1 | |
| EYTVAALSSWLEFTL | 131 | O60725 | |
| SEDEWNLLYVAVTRA | 911 | Q8NFZ0 | |
| DDVVSADNYTLDLWA | 91 | P24394 | |
| TTQLWDLTGFSYEDL | 471 | P41002 | |
| NADETWYLRATLDVV | 256 | P15813 | |
| GAYWDVVASSALLNL | 11 | Q6ZNG2 | |
| DTTASGLSWVLYNLA | 331 | P98187 | |
| DTTASGLSWVLYNLA | 331 | Q9HCS2 | |
| ELTDLLLWAIHYEES | 796 | Q86WZ0 | |
| ASYLASEISTWDGVI | 336 | Q12905 | |
| ESYEASLDTWTRDLE | 416 | P57058 | |
| EQSSLYFWDLLEGSE | 276 | Q6IMN6 | |
| ADAWRAAVLIYASDD | 431 | P35475 | |
| DYIALNEDLRSWTAA | 146 | P04439 | |
| AISSILGTWLDQYSE | 196 | Q12967 | |
| TTAAGALLYDNWVLT | 466 | O00187 | |
| WEALESLSQSLRDQY | 211 | Q17RN3 | |
| ALAIYQTLDDEWDTL | 221 | Q96DN0 | |
| LLYDASTKEWTADDV | 291 | Q5MNV8 | |
| SIASYSWLLDQQDVA | 256 | A6NK06 | |
| TTLSQFTDLNVYLWD | 536 | Q9UEF7 | |
| QWYTSIGEALLSATE | 2196 | Q8NDH2 | |
| DTTWYSSVDQLDLRV | 71 | P56749 | |
| DSLLPVDSYQSWALA | 161 | Q92826 | |
| WAADASNTISIIGDY | 541 | P54803 | |
| ADAYWDNITELDKLT | 3731 | Q9P225 | |
| AAQAEAADSWYLALL | 16 | Q9Y6X3 | |
| SSNIYSDSERILLSW | 1741 | Q6ZTR5 | |
| TSSLTLTFWYTLQDD | 356 | O94829 | |
| NLSYSWDLFLVNATE | 926 | Q8TDX9 | |
| NSLDREISAWYNLSI | 426 | Q9H159 | |
| EISAWYNLSITATEK | 431 | Q9H159 | |
| NSSDALDKIWYESLT | 51 | Q14568 | |
| ALTWTSLNIEAYLEN | 791 | Q8TE73 | |
| ALKTTDASNEEYSLW | 156 | O14713 | |
| AEHYWDLALSESVLE | 666 | O43395 | |
| TQYGWVLDAEVLLDS | 516 | Q969Z0 | |
| VSLWEEFSSSDLADL | 316 | Q86YC3 | |
| AVSWVSATYNLTAEE | 1871 | P98161 | |
| LWSAVLAENSDDYDL | 11 | P26022 | |
| SYTLLVEAWDSSNDT | 131 | P78504 | |
| DLYVAEALSTLESWR | 431 | Q5BJF6 | |
| FSLNLLDAWYDLTSS | 531 | Q86XP0 | |
| NIWDSEEYASVLQLL | 446 | Q9UBD5 | |
| AENESEQESWYLLLS | 181 | O14654 | |
| TNSYAAWAERISDLF | 96 | Q9H239 | |
| LSSLSRYSDNWEAIT | 1381 | P11717 | |
| ETAYGLLTAEASAVW | 376 | Q9Y3Y4 | |
| WSLQDTDAFVLVYDI | 81 | Q92737 | |
| TVDSSEVYSWLDSFL | 231 | Q9GZV3 | |
| NYLLSSSEDGTVRLW | 556 | Q15542 | |
| DTELLEWAFTSLSYL | 141 | O75691 | |
| DTTYLSQSWAALVVL | 511 | O75691 | |
| SDWRATNTDLLLAYA | 226 | Q7Z3J3 | |
| NSDYLLALSTENGLW | 226 | Q99523 | |
| WYRETLNISTSISDS | 176 | Q695T7 | |
| LRIISVEYDTSLSDW | 446 | Q96JX3 | |
| GEDTLVLSVWDSYAE | 1926 | Q6YHU6 | |
| VLSVWDSYAESRQLT | 1931 | Q6YHU6 | |
| WFLANLSYQEALSDT | 251 | Q8WV83 | |
| VYLSLLSDWDLSTAF | 96 | Q3MII6 | |
| LLEGLLESWSEYENN | 7016 | Q8NF91 | |
| ALLLWAQEQCATYES | 186 | Q8WXH0 | |
| AWTALETYLQLQEAF | 826 | Q9Y4C2 | |
| DLCSWEEAQLSSQLY | 71 | A6NCL1 | |
| LSVSIIDAWDITIAY | 506 | Q6UWF7 | |
| SLVANAWVTDRSYTL | 426 | Q5VVP1 | |
| IQQSAYDSKADIWSL | 191 | Q9P289 | |
| DEQWLIESLSDSTIY | 586 | Q9P2J5 | |
| ENLSSNSEILDWDIY | 271 | Q5TEA6 | |
| LLDDSFEWSLSNLAE | 371 | Q53T94 | |
| SDTDVLADACWALSY | 266 | P52294 | |
| SLVANAWVTDRSYTL | 426 | Q8IWB4 | |
| SVSLWDLLLSEYVGA | 1466 | P58107 | |
| VSVWDVLFSSYLSEA | 4256 | P58107 | |
| ISYWVDSQDQTLALD | 636 | Q9H3S1 | |
| ADGLVWESLDLYLSD | 296 | Q14524 | |
| EAVDSIFSYSALLWA | 186 | Q9NVD3 | |
| LTAQNALLEDDTYRW | 86 | Q11201 | |
| ILSASASALWNDEVD | 201 | Q9NR46 | |
| SDSLSENLSLFLWYL | 296 | Q03518 | |
| SDFAWSLSNDILVST | 221 | Q9H1Z4 | |
| SLSNLEEDAYWVQLD | 806 | P20701 | |
| DWFQTDSLVTIAIYT | 171 | Q7L1T6 | |
| TWDVHEYLNSLFEEL | 366 | Q6NSI8 | |
| ESSATDEAWRLLSTY | 1281 | Q12769 | |
| LVLQYFADAAEAASW | 746 | Q9NRC6 | |
| LYLGSEWNASNLEEL | 316 | Q8WYL5 | |
| SLAYADILLWAFDDT | 186 | Q6UX72 | |
| LQNATTETWEELLSY | 16 | Q8IZF4 | |
| RDVAQYLLSDSLFVW | 71 | Q9UKV5 | |
| SLVANAWVTDRSYTL | 426 | Q5VYP0 | |
| TDSYDANWFLQLLST | 256 | Q8N1K5 | |
| LTATLDNTLKLWDYS | 226 | Q86VZ2 | |
| IWDLATLQQLYDFTS | 726 | Q96KV7 | |
| DNLTSLSVYSEDGWD | 2086 | Q96RL7 | |
| LSVLSSLTYWEELAT | 646 | Q6GYQ0 | |
| YEAEEGSLWTLLLTS | 206 | Q96DV4 | |
| FAASTLYEQSVWITD | 111 | Q5JS37 | |
| SIPELSYIWELSDAD | 316 | Q8NFH8 | |
| SLVANAWVTDRSYTL | 426 | Q5TZJ5 | |
| YSWSQDSFDILQEIL | 291 | Q8WYR1 | |
| NAVNYISTVLADWAD | 541 | Q6NUQ1 | |
| SLVANAWVTDRSYTL | 426 | Q5VU36 | |
| QYWSSSFLVDLLAVA | 601 | Q9NX95 | |
| FYIDNAENTLWDSVT | 331 | Q5T4T6 | |
| STYINWEDNSVIFLL | 331 | P21359 | |
| AAYLVDSLWESSQEL | 481 | Q8WVM7 | |
| DDSQTIYVWLDALVN | 271 | Q96GW9 | |
| RWVTTASLLDYDTVA | 1031 | Q15393 | |
| SVHTDWLLDLYAGNI | 1001 | Q9BQI6 | |
| ALEDYLTTDLVETWL | 311 | Q9UK55 | |
| ALSYLEERGEQWTTD | 251 | Q96JL9 | |
| AVTASWDRTANLYDV | 296 | Q9Y2I8 | |
| WDRTANLYDVETSEL | 301 | Q9Y2I8 | |
| IESADLTSLNYLLSW | 416 | Q8NA56 | |
| AYVSWIDLSLIANDR | 211 | O43592 | |
| WYREALDISDSISES | 206 | Q9H1V8 | |
| VNWTARLAYLSDIFS | 1096 | Q6R2W3 | |
| SSFGQDILDALYWTA | 211 | Q6NXT6 | |
| TLVDESDLYNWEVAI | 31 | Q712K3 | |
| LSIDTWESYDLALQG | 161 | O43895 | |
| SDSELRVWDIAYLQE | 211 | Q9UNX4 | |
| LESIDTEFYNSLIWI | 696 | Q9H0M0 | |
| DYNLGSITESSLWRS | 196 | Q8WY21 | |
| WTLLDSTQRSLYSDV | 56 | Q9BUY5 | |
| LIWFSEASLSVYQSL | 361 | Q8IWR1 | |
| SNYVLTDEQSLWIED | 341 | Q96FV9 | |
| DEEEMLSDASLWTYS | 201 | Q9BU19 | |
| YTSDVSNWFALLESL | 281 | Q6ZT21 | |
| ETQAWSIATILETLY | 1516 | P35573 | |
| DTVWALSYLTDAGNE | 261 | O00629 | |
| ALDTEVASNRIYWSD | 431 | P01130 | |
| LAWIDLSFNDLTSID | 81 | Q96E66 |